[go: up one dir, main page]

WO2009000570A2 - Composition cosmétique contenant un extrait de champagne - Google Patents

Composition cosmétique contenant un extrait de champagne Download PDF

Info

Publication number
WO2009000570A2
WO2009000570A2 PCT/EP2008/054254 EP2008054254W WO2009000570A2 WO 2009000570 A2 WO2009000570 A2 WO 2009000570A2 EP 2008054254 W EP2008054254 W EP 2008054254W WO 2009000570 A2 WO2009000570 A2 WO 2009000570A2
Authority
WO
WIPO (PCT)
Prior art keywords
copolymer
acid
peg
alkyl
polymers
Prior art date
Application number
PCT/EP2008/054254
Other languages
German (de)
English (en)
Other versions
WO2009000570A3 (fr
Inventor
Ingrid Bitter
Original Assignee
Henkel Kommanditgesellschaft Auf Aktien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kommanditgesellschaft Auf Aktien filed Critical Henkel Kommanditgesellschaft Auf Aktien
Publication of WO2009000570A2 publication Critical patent/WO2009000570A2/fr
Publication of WO2009000570A3 publication Critical patent/WO2009000570A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Definitions

  • the invention relates to cosmetic compositions containing a champagne extract.
  • human hair is today treated in a variety of ways with hair cosmetic preparations. These include, for example, the cleansing of hair with shampoos, the care and regeneration with rinses and cures and the bleaching, dyeing and shaping of the hair with dyes, tinting agents, waving agents and styling preparations. In this case, means for changing or nuancing the color of the head hair play a prominent role.
  • the hair is treated with special active ingredients, for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • special active ingredients for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • This treatment depending on the formulation of the Combability, which improves the hold and the fullness of the hair, increases the shine and reduces the splitting rate.
  • These preparations contain, in addition to the usual components, for example for the cleaning of the hair, in addition to active ingredients which were formerly reserved for the hair aftertreatment agents.
  • the consumer thus saves an application step; At the same time, packaging costs are reduced because one product is less needed.
  • active ingredients both for separate aftertreatment agents and for combination preparations generally have a preferential effect on the hair surface.
  • active ingredients are known which give the hair shine, hold, fullness, better wet or dry combabilities or prevent splitting.
  • the internal structural cohesion of the hair fibers which can be greatly influenced, in particular, by oxidative and reductive processes such as dyeing and perming.
  • Detergents for skin and hair such as those commercially available as liquid soaps, shampoos, shower baths, bubble baths, shower gels and washing gels, not only have to have a good cleaning power, but should continue to be well tolerated by the skin and mucous membranes and also if used frequently, do not cause excessive defatting or dryness.
  • the consumer judges the performance characteristics but also on the amount and quality of the foam forming in the application, after the care effect and the freshness feeling. In modern skin and hair treatment products, one usually tries to combine all these requirements in one product.
  • shower baths are generally judged by the consumer either as a freshness-oriented product or as a nourishing product.
  • the freshness experience is judged positively, but skin-care aspects are missed by the consumer.
  • the nourishing products provide the skin and hair with nourishing substances, but have the consumer's criticized disadvantages of lesser freshness and possibly lower foaming power, which is usually associated with the feeling of poorer cleaning performance.
  • lipid-replenishing or moisturizing agents such as glycerine or water-binding hydrating substances
  • compositions desired by the consumer should be perceived by persons with dry skin as pleasantly cleansing and non-irritating, both during use and especially in the period after the application become. This applies both to agents which remain only briefly on the skin and are rinsed out again after a short exposure time, such as shower baths or hand washing pastes, hand wash creams or washing lotions, as well as for agents which are not completely rinsed off the skin after the cleansing application , such as make-up remover.
  • compositions are expected to have a significantly improved condition of the skin relative to the moisture balance of the dry skin.
  • the wetting of skin hair with impurities is significantly delayed. This lotus effect in turn contributes significantly to the fact that especially the dry and sensitive skin or dry, splattered and heavily stressed hair need not be cleaned so often.
  • the sensitive and dry skin and heavily stressed hair is significantly less damaged by the further action of surfactant-containing compositions.
  • plant extracts are already widely used in cosmetic preparations. There they show both a nourishing effect and a hair-altering effect such as the coloring extracts of henna. But especially with plant extracts there is always a risk of incompatibilities on the part of the consumer. Especially sought after are plant extracts, which humans have been using for a long time in a variety of ways, possibly also for healing purposes or for nutrition or as a stimulant.
  • a good sommelier for example, is able to distinguish between two successive vintages in terms of taste, given the same situation, the same grape variety and the same aging of the wine. Therefore, it is not surprising if a wine extract is not the same as wine extract. Rather, it is also decisive here, from which grape variety, from which location, on which soil the relevant extracted plants have grown. There are now more than 16,000 grape varieties known. Nevertheless, according to the INCII declaration, only wine extracts are labeled "vitis vinifera”.
  • an extract of the champagne not only has the excellent known effects of champagne as such, but also has significant advantages in some important for the user of cosmetic products points.
  • substances may also be contained by the champagne in these cosmetic compositions, which show sensitizing or carcinogenic or toxic properties.
  • a champagne extract is obtained which does not contain any ingredients having adverse effects.
  • the ingredients of the champagne which are relevant for the stimulating, anti-inflammatory, allergy-calming, astringent, antioxidant and vascular-strengthening effects, are still included.
  • the champagne extract can be added to a process step in which the temperature-sensitive ingredients are no longer subject to decomposition.
  • the champagne extract according to the invention in cosmetic compositions together with polymers, in particular with cationic and amphoteric polymers, leads to a significantly improved moisture retention of the treated skin and hair. Associated with this, the skin feel and feel of dry skin and dry hair, as well as wet skin and wet hair, are described as being much more pleasant, gentler, softer, smoother and supple by subjects.
  • compositions according to the invention are distinguished by a markedly improved condition of the skin and of the hair in relation to the moisture balance of the dry skin and the dry hair.
  • the agents according to the invention lead to a significantly delayed re-soiling of the skin and hair.
  • the wetting of skin and hair with impurities and water is significantly delayed.
  • This lotus effect in turn contributes significantly to the fact that especially dry and sensitive skin as well as dry and brittle hair do not have to be treated as frequently compared to conventional cosmetic agents according to the prior art without the composition according to the invention.
  • the sensitive and dry skin and dry and damaged hair are significantly less damaged.
  • keratinic fibers are understood to mean furs, wool, feathers and, in particular, human hair.
  • skin is meant the external surface of the human including the skin and mucous membrane in the genital area as well as the scalp.
  • a first subject of the present invention are therefore cosmetic compositions containing a champagne extract.
  • a particular embodiment of the present invention are cosmetic compositions comprising: a) an aqueous surfactant base, b) a champagne extract and c) a polymer.
  • a champagne extract like a wine extract, is usually obtained from the leaves, vines or grapes, and also from the aspect that the champagne extract and wine extract have the same INCII name "vinis vinifera”, both extracts are distinctly different This is based on the special way in which champagne is cultivated and cared for, as well as on the special way of processing the champagne grapes, so that when processing the champagne grapes great emphasis is placed on ensuring that the color and bitter substances of the grapes do not flow into the grapes
  • the champagne extract does not or only to a very minor extent contain these ingredients as an impurity, hence the characteristics of a wine extract and of the champagne extract of the present invention differ.
  • Suitable extractants for producing the champagne extract according to the invention may include water, alcohols and ethoxylates of lower alcohols such as polyglycols and polypropylene glycols with a degree of ethoxylation of 1 mole of ethylene oxide up to 100 moles of ethylene oxide, preferably from 1 mole to 50 moles, more preferably from 1 mole to 20 Mol ethylene oxide, and mixtures thereof are used.
  • lower alcohols such as polyglycols and polypropylene glycols with a degree of ethoxylation of 1 mole of ethylene oxide up to 100 moles of ethylene oxide, preferably from 1 mole to 50 moles, more preferably from 1 mole to 20 Mol ethylene oxide, and mixtures thereof are used.
  • alcohols are lower alcohols such as ethanol, isopropanol, propanol, butanol, isobutanol, tertiary butanol, pentanols, hexanols, heptanols and octanols, and their ethoxilates with degrees of ethoxylation as described above, but especially polyhydric alcohols such as ethylene glycol, propylene glycol and glycerol and their ethoxylates with ethoxylation levels as previously shown, both as sole extractant and in Mixture with water, preferred.
  • Plant extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.
  • extracts based on water / glycerol in a ratio of 1:10 to 10: 1 are also very well suited. Extracts having excellent activity are obtained when pure propylene glycol is used as the extractant.
  • a champagne extract which is most preferred according to the invention is obtained by subjecting the champagne produced by the customary processes to a liquid-liquid extraction.
  • the champagne is extracted at room temperature with a circulating mixture of glycerol and water. Obtained is about 0.1 to 10% champagne extract.
  • the ratio of glycerol to water in the extraction is about 10: 1 to 1: 1.
  • a ratio of 10: 1 to 2: 1 is preferred.
  • An example of a very particularly preferred champagne extract is the commercial product under the name Champagne Extract® Company Botanica.
  • the champagne extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 0.1 to 80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture.
  • the teaching of the invention also includes the recognition that instead of the champagne extract the respectively isolated ingredients of the champagne can be used.
  • the present invention also encompasses the teaching that the extracts according to the invention can additionally be enriched with the abovementioned individual compounds, which may be contained in the respective extract, both as a respective individual compound and as a mixture of different compounds.
  • the use of the champagne extract is preferred according to the invention.
  • the champagne extract according to the invention is in the cosmetic preparations in amounts of 0.001 to 15 wt.%, Preferably in amounts of 0.01 to 15 wt.%, Particularly preferably in amounts of 0.01 to 10 wt.% And most preferably in amounts of from 0.1 to 5% by weight, based in each case on the total composition.
  • compositions according to the invention are described below.
  • respective synergistic constituents of the active ingredient complex according to the invention are described in the description of the respective raw material.
  • the surfactants essentially comprise two groups, the surfactants and the emulsifiers.
  • surfactants (E) is understood to mean surface-active substances which can form adsorption layers on upper and boundary surfaces or which can aggregate in volume phases to give micelle colloids or lyotropic mesophases.
  • anionic surfactants consisting of a hydrophobic radical and a negatively charged hydrophilic head group
  • amphoteric surfactants which carry both a negative and a compensating positive charge amphoteric surfactants which carry both a negative and a compensating positive charge
  • cationic surfactants which, in addition to a hydrophobic radical, have a positively charged hydrophilic group
  • nonionic surfactants which have no charges but strong dipole moments and are highly hydrated in aqueous solution.
  • the following surfactants are exclusively known compounds. Regarding the structure and production of these substances, reference should be made to relevant reviews.
  • Suitable anionic surfactants (E1) in preparations according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
  • anionic surfactants are alkylbenzenesulfonates, alkanesulfonates, olefinsulfonates, alkyl ether sulfonates, glycerol ether sulfonates, ⁇ -methyl ester sulfonates, sulfo-fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerol amine ether sulfates, hydroxymethylene ether sulfates, monoglyceride (ether) sulfates, fatty acid amide (ether) sulfates, mono- and dialkyl sulfosuccinates, mono- and dialkyl sulfosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and their salts, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, acyl lac
  • anionic surfactants contain polyglycol ether chains, these may have a conventional, but preferably a narrow homolog distribution.
  • particularly suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group, linear and branched fatty acids having 8 to 30 C Atoms (soaps),
  • Ci 2 - Ci ⁇ -acyl isethionates It is known to bring the sodium salts of Ci 2 - Ci ⁇ -acyl isethionates similar to fatty acid-based soaps by kneading, pilching, extrusion, extrusion, cutting and piece pressing in a suitable form for transport and use. In this way, needles, granules, noodles or bars can be produced.
  • One application of the acyl isethionates are toilet soap pieces and syndets,
  • Sulfobernsteinklado- and -dialkylester having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester having 8 to 24 carbon atoms in the Alkyl group and 1 to 6 oxyethyl groups.
  • the Sulfobernsteinklamonoalkyl (C 8 - C 24 ) ester dinatrium salts are prepared by known methods z. B. prepared by reacting maleic anhydride with a fatty alcohol having 8 - 24 carbon atoms to maleic acid monoester of the fatty alcohol and sulfites this with sodium sulfite to Sulfobernsteinklaester.
  • Sulfosuccinic acid esters are derived from fatty alcohol fractions having 12- 18 C atoms, as z. B. from coconut oil or Kokosfettkladester are accessible by hydrogenation.
  • Alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 C atoms and x 0 or 1 to 12,
  • Hydroxysulfonates essentially corresponding to at least one of the following two formulas or mixtures thereof and salts thereof, CH 3 - (CH 2 ) y -CHOH- (CH 2 ) p - (CH-SO 3 M) - (CH 2 ) z -CH 2 -O- (C n H 2n O) x -H, and / or
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 C atoms,
  • R 1 (OCH 2 CH 2 ) n -O- (PO-OX) -OR 2 , in which R 1 is preferably an aliphatic hydrocarbon radical having 8 to 30
  • R 2 is hydrogen, a radical (CH 2 CH 2 O) n R 2 or X, n for
  • Numbers from 1 to 10 and X is hydrogen, an alkali or alkaline earth metal or
  • NR 3 R 4 R 5 R 6 where R 3 to R 6 independently of one another represent hydrogen or a C 1 to C 4 hydrocarbon radical, is a sulfated fatty acid alkylene glycol ester of the formula RCO (Al k O) n SO 3 M in the RCO-- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, Alk for CH 2 CH 2 , CHCH 3 CH 2 and / or CH 2 CHCH 3 , n for numbers from 0.5 to 5 and M for a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or ammonium ion, such as + NR 3 R 4 R 5 R 6 , with R 3 to R 6 are independently hydrogen or a C1 to C4 - hydrocarbon radical,
  • R 8 OC- (OCH 2 CH 2 ) x -OCH 2 - [CHO (CH 2 CH 2 O) y H] -CH 2 O (CH 2 CH 2 O) z -SO 3 X in which R 8 is CO for a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z in total for 0 or for numbers from 1 to 30, preferably 2 to 10, and X stands for an alkali or alkaline earth metal.
  • Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts.
  • R 8 CO is a linear acyl radical having 8 to 18 carbon atoms, Amide ether carboxylic acids, R 1 -CO-NR 2 -CH 2 CH 2 -O- (CH 2 CH 2 ⁇ ) n CH 2 COOM, with R 1 as the straight or branched alkyl or alkenyl radical having a number of carbon atoms in the chain of 2 to 30, n is an integer from 1 to 20, and R 2 is hydrogen, methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl or iso-butyl, and M is Is hydrogen or a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or an ammonium ion, such as + NR 3 R 4 R 5 R 6 , with R 3 to R 6 independently of one another for hydrogen or a C1 to C4 hydrocarbon radical
  • Condensation products of a water-soluble salt of a water-soluble protein hydrolyzate-fatty acid condensation product are prepared by condensation of C8-C30 fatty acids, preferably of fatty acids having 12-18 C atoms with amino acids, mono-, di- and water-soluble oligopeptides and mixtures of such products as obtained in the hydrolysis of proteins.
  • These protein hydrolyzate-fatty acid condensation products are neutralized with a base and are then preferably present as alkali, ammonium, mono-, di- or trialkanolammonium salt.
  • Such products are available under the trademark Lamepon® ®, Maypon ®, Gluadin® ®, Hostapon® ® KCG or Amisoft ® has long been in the trade,
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having 10 to 18 C atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 C atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethylester with 8 to 18 C Atoms in the alkyl group and 1 to 6 oxyethyl groups, Monoglycerdisulfate, alkyl and Alkenyletherphosphate and Eiweissfettkladensate.
  • compositions according to the invention it is particularly advantageous if mild anionic surfactants are used as anionic surfactants.
  • mild anionic surfactants are used as anionic surfactants.
  • the effect of the composition according to the invention is substantially increased.
  • millild surfactants is understood by the person skilled in the art as surfactants, which are found in the numerous test methods such as the HET-CAM test, the neutral redness test, the BUS model (bovine and skin model), the human skin model, the Zeize test, the Draize test, the Armflexwashtest or the Duhringhunttest etc. have proven to be mild surfactants.All in common with all test models is that in principle is measured against a standard to which the measurement results are obtained.In each of these test models there is a threshold below which is spoken of "mild surfactants". This threshold is for example in the HET-CAM test 1, 5.
  • surfactants which have a relative irritation score of 1, 5 and smaller, for example, in the HET-CAM test are known as "mild.”
  • a surfactant gives a different score in each test model.
  • a cocamidopropyl betaine may even be classified as "irritating" in the HET-CAM test, while in the other test models it is more likely to be considered mild surfactants.
  • a common and accepted classification defines surfactants as mild if they have a relative irritation score of less than 1.5 in the HET-CAM test. According to the invention, however, such surfactants are preferably used and understood as "mild surfactants" which are classified as "mild” in all current test models.
  • Particularly preferred surfactants used are mild surfactants which have a relative irritation score of less than 1.2 in the HET-CAM test.
  • Very mildly preferred surfactants used are surfactants which have a relative irritation score of less than 0.8 in the HET-CAM test.
  • the corresponding HET-CAM tests are carried out with a surfactant concentration of 3.0% active substance of the particular surfactant.
  • anionic surfactants have proven to be mild to particularly mild and are particularly preferred according to the invention:
  • Acyl isethionates having 8 to 24 carbon atoms in the acyl group are long known, skin-friendly surfactants, which are accessible by esterification of fatty acids with the sodium salt of 2-hydroxyethane-sulfonic acid (isethionic acid). If you for this esterification fatty acids with 8 to 24 carbon atoms, ie z.
  • Ci 2 - cis-acyl isethionates It is known to bring the sodium salts of Ci 2 - cis-acyl isethionates similar to fatty acid-based soaps by kneading, pilering, extrusion, extrusion, cutting and piece pressing in a suitable form for transport and use. In this way, needles, granules, noodles or bars can be produced.
  • One application of the acyl isethionates are toilet soap pieces and syndets,
  • Sulfobernsteinklado- and dialkyl esters having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups.
  • the Sulfobernsteinklamonoalkyl (C 8 - C 24 ) ester dinatrium salts are prepared by known methods z. B. prepared by reacting maleic anhydride with a fatty alcohol having 8 - 24 carbon atoms to maleic acid monoester of the fatty alcohol and sulfites this with sodium sulfite to Sulfobernsteinklaester.
  • Sulfosuccinic acid esters are derived from fatty alcohol fractions having 12- 18 C atoms, as z. B. from coconut oil or Kokosfett Anlagenremethylester are accessible by hydrogenation.
  • Alkylpolyglykolethersulfate of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 carbon atoms and x 0 or 1 to 12,
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 C atoms,
  • R 1 (OCH 2 CH 2) n -O- (PO-OX) -OR 2, where R 1 is preferably an aliphatic hydrocarbon radical having from 8 to 30
  • R 2 is hydrogen, a radical (CH 2 CH 2 O) n R 2 or X, n for
  • Numbers from 1 to 10 and X is hydrogen, an alkali or alkaline earth metal or
  • R 3 to R 6 independently of one another represent hydrogen or a C 1 to C 4 hydrocarbon radical
  • R 8 OC- (OCH 2 CH 2 ) x -OCH 2 - [CHO (CH 2 CH 2 O) y H] -CH 2 O (CH 2 CH 2 O) z -SO 3 X in which R 8 is CO for a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z in total for 0 or for numbers from 1 to 30, preferably 2 to 10, and X stands for an alkali or alkaline earth metal.
  • Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts.
  • monoglyceride sulfates are used, in which R 8 CO is a linear acyl radical having 8 to 18 carbon atoms,
  • Amide ether carboxylic acids R 1 -CO-NR 2 -CH 2 CH 2 -O- (CH 2 CH 2 O) n CH 2 COOM, with R 1 as the straight-chain or branched alkyl or alkenyl radical having a number of carbon atoms in the chain of 2 to 30, n is an integer from 1 to 20, and R 2 is hydrogen, methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl or iso-butyl, and M is Is hydrogen or a metal such as alkali metal, in particular sodium, potassium, lithium, alkaline earth metal, in particular magnesium, calcium, zinc, or an ammonium ion, such as + NR 3 R 4 R 5 R 6 , with R 3 to R 6 independently of one another for hydrogen or a C1 to C4 hydrocarbon radical.
  • Such products are obtainable, for example, by the company Chem Y under the product name Akypo ®.
  • Condensation products of a water-soluble salt of a water-soluble protein hydrolyzate-fatty acid condensation product are prepared by condensation of C8-C30 fatty acids, preferably of fatty acids having 12-18 C atoms with amino acids, mono-, di- and water-soluble oligopeptides and mixtures of such products as obtained in the hydrolysis of proteins.
  • These protein hydrolyzate-fatty acid condensation products are neutralized with a base and are then preferably present as alkali, ammonium, mono-, di- or trialkanolammonium salt.
  • Such products are available under the trademark Lamepon® ®, Maypon ®, Gluadin® ®, Hostapon® ® KCG or Amisoft ® has long been in the trade,
  • the mild anionic surfactants contain polyglycol ether chains, it is particularly preferred that they have a narrow homolog distribution. Also, in the case of mild anionic surfactants having polyglycol ether units, it is preferred that the number of glycol ether groups is 1 to 20, preferably 2 to 15, more preferably 2 to 12. Particularly mild anionic surfactants having polyglycol ether without restricted homologue distribution may for example be obtained even if the one hand, the number of polyglycol ether amounts to 4 to 12 and are selected as a counter ion Zn or Mg ions. Examples of these are the commercial product Texapon ASV ®.
  • mild and anionic surfactants mentioned heretofore and in the following can also be used in the form of their salts.
  • Particularly suitable mild anionic surfactants are in each case in the form of the lithium, magnesium, zinc, sodium, potassium and ammonium and the mono-, di- and trialkanolammonium salts having 1 to 4 carbon atoms in the alkanol group.
  • the preferred ammonium ions are in addition to the ammonium ion as such monomethylammonium, dimethylammonium, Trimethylammonium, monoethylammonium, diethylammonium, triethylammonium, monopropylammonium, dipropylammonium, tripropylammonium,
  • the teaching of the invention also does not include the other explicitly mentioned ammonium ions of these alkanolammonium salts.
  • mild anionic surfactants which are most preferably used in the composition according to the invention are alkyl and / or
  • G glycoside unit derived from a sugar with 5 or 6 carbon atoms, p number from 1 to 10.
  • the mild anionic surfactant is preferably selected from the anionic alkyl polyglycosides, the ether carboxylic acids, the acyl isethionates, the protein fatty acid condensates, the taurates, the sulfosuccinates, the fatty acid amide ether sulfates, the NRE fatty alcohol ether sulfates, the acyl glutamates and the acylasparaginates and mixtures thereof ,
  • anionic alkyl polyglucosides such as alkyl oligoglycoside carboxylates, sulfates, phosphates and / or isethionates, ether carboxylic acids, acyl isethionates and also taurates and mixtures thereof.
  • anionic alkyl polyglucosides and ether carboxylic acids and mixtures thereof are particularly preferred.
  • the mixing ratio of these surfactants is at least 10: 1 to 1:10.
  • Preferred is a mixing ratio of 5: 1 to 1: 5, more preferably from 2.5: 1 to 1: 2.5, and most preferably from about 1, 5: 1 to 1: 1.5.
  • the foaming is considerably improved .
  • the foam is characterized in particular by a fine-pored, dense, creamy appearance.
  • the foam is described as pleasantly soft and supple and easy to spread.
  • the foam is firm and well palpable. He shows a certain stamina and does not run spontaneously but only after a few minutes. This favors the already described easy spreadability of the foam.
  • compositions according to the invention in particular when further formulated in combination with cationic and / or amphoteric polymers.
  • at least one hydroxyl group is preferably in at least one of the radicals G by -O-Ci.-
  • 2- alkenyl-COOM, -OSO 3 M, -OP (O) (OM) 2 or -O-CH 2 -CH 2 -SO 3 M with M H, alkali metal, NH 4 or one of the aforementioned counterions such as Zn, Mg, alkanolammonium replaced.
  • the radical is 0-CH 2 -COONa.
  • alkyl oligoglycoside carboxylate in which the alkyl radical is a lauryl radical.
  • a Laurylglucosidcarboxylat as it is available as Plantapon ® LCG Cognis Germany.
  • the glycoside units G are preferably derived from aldoses or ketoses.
  • the aldoses are used.
  • glucose is particularly suitable for their easy accessibility and technical availability.
  • the alkylglycosides which are particularly preferably used as starting materials are therefore the alkylglucosides.
  • alkyl glycosides having an average degree of oligomerization p of 1.1 to 3.0 are used. Particular preference is given to those alkyl glycosides whose degree of oligomerization is less than 1.5 and, in particular, lies between 1.1 and 1.4.
  • the alkyl radical R is derived from primary alcohols having 6 to 22, preferably 12 to 18 carbon atoms. Typical examples are caproic alcohol, caprylic alcohol, capric alcohol, lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol and behenyl alcohol and technical fractions which, in addition to the saturated alcohols mentioned, may also contain portions of unsaturated alcohols and which are based on natural fats and oils, for example palm oil, palm kernel oil, coconut oil or beef tallow are obtained. The use of technical coconut oil is particularly preferred here.
  • the alkyl glycosides can also be derived from synthetic primary alcohols having 6 to 22 carbon atoms, in particular the so-called oxo alcohols, which have a proportion of 5 to 40% by weight of branched isomers.
  • Particularly preferred alkyl radicals are those having 8/10, 12/14, 8 to 16, 12 to 16 or 16 to 18 carbon atoms. Mixtures of the alkyl radicals result in a production starting from natural fats and oils or mineral oils.
  • the alkyl or alkenyl oligoglycoside carboxylates, phosphates, sulfates or isethionates used according to the invention can be prepared by known processes.
  • the carboxylates are prepared, for example, by reacting the alkyloligoglycosides with salts of chlorocarboxylic acids in the presence of bases. For example, it can be reacted with 2-chloroacetic acid sodium salt in the presence of NaOH. In the reaction, both the hydroxyl groups in the ring and the -CH 2 -OH group can be reacted. The degree of conversion depends inter alia on the stoichiometry of the feedstock.
  • the alkyl oligoglycosides are reacted at least on the -CH 2 -OH group, optionally with an agent capable of reacting one or more of the hydroxyl groups on the ring.
  • Other hydroxyl groups may also be etherified, for example.
  • the preparation of the isethionates is also carried out by known methods of the prior art. It is also known that the products can be used for hair and body care. In particular, aqueous detergent mixtures are described which contain alkyloligoglycoside isethionates and, for example, further anionic surfactants.
  • the preparation of the sulfates is also carried out according to the prior art.
  • the corresponding alkyl glycoside can be reacted with gaseous sulfur trioxide or with sulfuric acid followed by neutralization.
  • Cosmetic and pharmaceutical preparations containing the alkyloligoglycoside sulfates are also known.
  • detergent mixtures of alkyl oligoglycoside sulfates and alkyl ether phosphates are described which can be used, for example, in hair rinses, hair dyes or hair waving agents.
  • the mild anionic surfactants used according to the invention and particularly preferably the alkyl and / or alkenyl oligoglycoside carboxylates, sulfates, phosphates and / or isoethionates are used in an amount of from 0.1 to 25% by weight, more preferably from 0.1 to 15 wt .-% and most preferably used in an amount of 0.5 to 10.0 wt.%
  • the mild anionic surfactants used and particularly preferably the alkyl and / or alkenyl oligoglycoside carboxylates, sulfates, phosphates and / or isoethionates can completely or partially replace the customary anionic surfactants in these compositions.
  • the mild anionic surfactants according to the invention can be used as the sole anionic surfactant in the compositions, or mixtures of these mild anionic surfactants can be used with each other or with other conventional anionic surfactants. These conventional anionic surfactants are explained in more detail later.
  • the mild anionic surfactants and other anionic surfactants may be present in a weight ratio ranging from 5: 0.05 to 1: 2, more preferably 3: 0.5 to 1: 2, in particular 2.5: 0.5 to 1: 1, 5 and most preferably 1, 5: 1 to 1: 1, 5 are present.
  • amphoteric and zwitterionic surfactants also show a synergistic effect with the champagne extracts according to the invention. This synergistic effect may be due to increased deposition of the extract of champagne on the surface of the skin and hair, which manifests itself in the overall cosmetic appearance of the skin and hair.
  • the particular charge effects of amphoteric and zwitterionic surfactants seem to play a role here.
  • Zwitterionic surfactants are those surface-active compounds which carry in the molecule at least one quaternary ammonium group and at least one -COO * " 'or -SO 3 ' " 'group.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyl-dimethylammonium glycinate, and Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and Kokosacylaminoethylhydroxyethylcarboxymethylglycinat.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INC
  • Ampholytic surfactants (E3) are meant those surface-active compounds which, in addition to a C - contain at least one free amino group and at least one -COOH or -SO 3 H group in the molecule and alkyl or acyl group of forming inner salts - C 24 are capable.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C Atoms in the alkyl group.
  • amphoteric or zwitterionic surfactants are alkylbetaines, alkylamidobetaines, amino-propionates, aminoglycinates, imidazolinium betaines and sulfobetaines.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C 2 - C 8 - sarcosine.
  • Nonionic surfactants (E4) contain as hydrophilic group e.g. a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group. Such compounds are, for example
  • Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil
  • Polyol fatty acid esters such as the commercially available product ® Hydagen HSP (Cognis) or Sovermol ® - types (Cognis), alkoxylated triglycerides, alkoxylated fatty acid alkyl esters of the formula (E4-I)
  • R 1 CO is a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms
  • R 2 is hydrogen or methyl
  • R 3 is linear or branched alkyl radicals having 1 to 4 carbon atoms
  • w is a number from 1 to 20 stands
  • R 4 is an alkyl or alkenyl radical having 4 to 22 carbon atoms
  • G is a sugar radical having 5 or 6 carbon atoms
  • p is a number from 1 to 10. They can be obtained by the relevant methods of preparative organic chemistry.
  • the alkyl and alkenyl oligoglycosides can be derived from aldoses or ketoses with 5 or 6 carbon atoms, preferably glucose.
  • the preferred alkyl and / or alkenyl oligoglycosides are thus alkyl and / or alkenyl oligoglucosides.
  • alkyl and / or alkenyl oligoglycosides whose degree of oligomerization is less than 1.7 and in particular between 1.2 and 1.4 are preferred.
  • the alkyl or alkenyl radical R 4 can be derived from primary alcohols having 4 to 1 1, preferably 8 to 10 carbon atoms. Typical examples are butanol, caproic alcohol, caprylic alcohol, capric alcohol and undecyl alcohol and their technical mixtures, as obtained, for example, in the hydrogenation of technical fatty acid methyl esters or in the hydrogenation of aldehydes from Roelen's oxosynthesis.
  • the alkyl or alkenyl radical R 15 can also be derived from primary alcohols having 12 to 22, preferably 12 to 14 carbon atoms.
  • Typical examples are lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, brassidyl alcohol, and technical mixtures thereof which can be obtained as described above.
  • R 5 is CO for an aliphatic acyl radical having 6 to 22 carbon atoms
  • R 6 is hydrogen, an alkyl or hydroxyalkyl radical having 1 to 4 carbon atoms
  • [Z] is a linear or branched polyhydroxyalkyl radical having 3 to 12 carbon atoms and 3 to 10 hydroxyl groups stands.
  • the fatty acid N-alkylpolyhydroxyalkylamides are known substances, usually by reductive Amination of a reducing sugar with ammonia, an alkylamine or an alkanolamine and subsequent acylation with a fatty acid, a fatty acid alkyl ester or a fatty acid chloride can be obtained.
  • the fatty acid N-alkylpolyhydroxyalkylamides are derived from reducing sugars having 5 or 6 carbon atoms, especially glucose.
  • the preferred fatty acid N-alkylpolyhydroxyalkylamides are therefore fatty acid N-alkylglucamides as represented by the formula (E4-IV):
  • Glucamides of the formula (E4-IV) in which R 8 is hydrogen or an alkyl group and R 7 CO for the acyl radical of caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitic acid are preferably used as the fatty acid N-alkylpolyhydroxyalkylamides , Stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, arachidic acid, gadoleic acid, behenic acid or erucic acid or their technical mixtures.
  • fatty acid N-alkylglucamides of the formula (E4-IV) which are obtained by reductive amination of glucose with methylamine and subsequent acylation with lauric acid or C12 / 14 coconut fatty acid or a corresponding derivative.
  • the polyhydroxyalkylamides can also be derived from maltose and palatinose.
  • the sugar surfactants may preferably be present in the agents used according to the invention in amounts of from 0.1 to 20% by weight, based on the total agent. Amounts of 0.5-15% by weight are preferred, and most preferred are amounts of 0.5-7.5% by weight.
  • nonionic surfactants are fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, mixed ethers or mixed formalin, protein hydrolysates (especially wheat-based vegetable products) and polysorbates.
  • Preferred nonionic surfactants are the alkylene oxide addition products of saturated linear fatty alcohols and fatty acids each having from 2 to 30 moles of ethylene oxide proven per mole of fatty alcohol or fatty acid and the sugar surfactants. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants.
  • the alkyl radical R contains 6 to 22 carbon atoms and may be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals.
  • Such alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl.
  • oxo-alcohols When so-called "oxo-alcohols" are used as starting materials, compounds with an odd number of carbon atoms in the alkyl chain predominate.
  • the compounds used as surfactant with alkyl groups may each be uniform substances. However, it is usually preferred to start from the production of these substances from native plant or animal raw materials, so as to obtain substance mixtures with different, depending on the particular raw material alkyl chain lengths.
  • both products with a "normal” homolog distribution and those with a narrow homolog distribution can be used.
  • normal homolog distribution are meant mixtures of homologs which are obtained in the reaction of fatty alcohol and alkylene oxide using alkali metals, alkali metal hydroxides or alkali metal alcoholates as catalysts. Narrowed homolog distributions, on the other hand, are obtained when, for example, hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or alcoholates are used as catalysts. The use of products with narrow homolog distribution may be preferred.
  • nonionic surfactants As additives for further improving the skin feel during and after the application, nonionic surfactants have also proven useful, their additional use for the preparation of the compositions according to the invention is recommended can be. Particular preference is therefore given to compositions according to the invention having an additional content of from 0.1 to 20% by weight of nonionic surfactants having an HLB value of from 2 to 18.
  • Such products can be obtained by addition of ethylene oxide onto z.
  • the HLB value means the proportion of hydrophilic groups, eg. As to glycol ether or polyol groups based on the total molecule and it is calculated by the relationship
  • wt .-% L of the proportion by weight of lipophilic groups, ie z. B. to alkyl or acyl groups having 6-30 carbon atoms in the surfactant molecule represents.
  • the cationic surfactants (E5) form the last group of surfactants.
  • Cationic surfactants are characterized as part of the active ingredient complex according to the invention in that, like the amphoteric and zwitterionic surfactants, they contribute to a significantly improved cosmetic appearance of the skin.
  • the cationic charge ensures a good bond to the rather negatively charged surfaces, especially of stressed skin.
  • more hydrophobically structured active ingredients can accumulate.
  • an overall increased deposition of care substances on the surface of the skin is effected.
  • the skin feeling is described as pleasantly soft to velvety soft.
  • Cationic surfactants (E5) are generally derived from ammonium ions and have a structure (NR 1 R 2 R 3 R 4 ) + with a correspondingly negatively charged counterion. Such cationic ammonium compounds are well known to those skilled in the art. Further cationic surfactants are, for example, the esterquats or the imidazolium compounds. Cationic surfactants (E5) of the quaternary ammonium compound type, the esterquats, the imidazolines and the amidoamines are particularly preferably used according to the invention. Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides.
  • alkyltrimethylammonium chlorides dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, eg. Cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, as well as the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.
  • the long alkyl chains of the above-mentioned surfactants preferably have 8 to 30 carbon atoms.
  • Typical examples of cationic surfactants are quaternary ammonium compounds and ester quats, especially quaternized fatty acid trialkanolamine ester salts.
  • cationic compounds containing behenyl radicals in particular the substances known under the name of behentrimonium chloride or bromide (docosanyltrimethylammonium chloride or bromide), can be used with particular preference.
  • Other preferred QAVs have at least two behenyl residues.
  • these substances are, for example, under the designations Genamin ® KDMP (Clariant).
  • Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
  • Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are marketed under the trade names Stepantex® ®, ® and Dehyquart® Armocare® ®.
  • the agents according to the invention may contain at least one quaternary imidazoline compound, ie a compound which has a positively charged imidazoline ring.
  • the formula (E5-V) shown below shows the structure of these compounds.
  • the radicals R independently of one another each represent a saturated or unsaturated, linear or branched hydrocarbon radical having a chain length of 8 to 30 carbon atoms.
  • the preferred compounds of formula (E5-V) for R each contain the same hydrocarbon radical.
  • the chain length of the radicals R is preferably 12 carbon atoms. Particular preference is given to compounds having a chain length of at least 16 carbon atoms and very particularly preferably having at least 20 carbon atoms.
  • a very particularly preferred compound of the formula I has a chain length of 21 carbon atoms. A commercial product of this chain length is known, for example, under the name Quaternium-91.
  • the counterions also include the halides, such as chloride, fluoride, bromide, or else phosphates.
  • the imidazolines of the formula (E5-V) are present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably in amounts of from 0.05 to 10% by weight and very particularly preferably in amounts of from 0.1 to 7 , 5% by weight. The very best results are obtained with amounts of from 0.1 to 5% by weight, based in each case on the total composition of the particular agent.
  • the alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines.
  • a according to the invention particularly suitable compound from this group of substances under the name Tegoamid ® S 18 stearamidopropyldimethylamine commercially available dimethylamine.
  • the alkylamidoamines can be present both as such and converted by protonation in accordance acid solution into a quaternary compound in the composition, they but of course also as permanently quaternary compound can be used in the compositions of the invention.
  • Examples of permanently quaternized amidoamines include the raw materials with the trade name Rewoquat ® UTM 50, Lanoquat ® DES-50 or Empigen CSC.
  • the cationic surfactants (E5) are contained in the agents used according to the invention preferably in amounts of 0.05 to 10 wt .-%, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • mild cationic surfactants include in particular alkylamidoamines, quaternized amidoamines, esterquats and cationic surfactants having at least one behenyl radical in the molecule.
  • Cationic, zwitterionic and / or amphoteric surfactants and mixtures thereof may be preferred according to the invention.
  • Anionic surfactants are used in particular when the compositions according to the invention are to be used as shower baths.
  • the surfactants (E) are used in amounts of 0.05-45% by weight, preferably 0.1-30% by weight and very particularly preferably 0.5-25% by weight, based on the total agent used according to the invention ,
  • Emulsifiers effect at the phase interface the formation of water- or oil-stable adsorption layers, which protect the dispersed droplets against coalescence and thus stabilize the emulsion.
  • Emulsifiers are therefore constructed like surfactants from a hydrophobic and a hydrophilic part of the molecule. Hydrophilic emulsifiers preferably form O / W emulsions and hydrophobic emulsifiers preferably form W / O emulsions.
  • An emulsion is to be understood as meaning a droplet-like distribution (dispersion) of a liquid in another liquid under the expense of energy in order to create stabilizing phase interfaces by means of surfactants. The Selection of these emulsifying surfactants or emulsifiers depends on the substances to be dispersed and the respective outer phase and the fineness of the emulsion.
  • Emulsifiers which can be used according to the invention are, for example
  • Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
  • Sterols are understood to mean a group of steroids which have a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
  • glucose phospholipids e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol, Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hy- droxystearat (Dehymuls ® PGPH commercial product)
  • Linear and branched fatty acids with 8 to 30 C atoms and their Na, K, ammonium, Ca, Mg and Zn salts.
  • a per se known emulsifier of the water-in-oil type in an amount of about 1 - 5 wt .-% proved.
  • This is a mixed ester which is a condensation product of a pentaerythritol di-fatty acid ester and a citric acid di-fatty alcohol ester. The following formula describes the mixed ester in more detail:
  • R 1 OOC-CH 2 - (CHOH-COOR 1 ) -CH 2 -COO-CH) 2 - [C (CH 2 OH) (COOR 2 ) 2]
  • R 1 and R 2 are saturated or unsaturated, linear or branched Fatty alcohol residues with a chain length of 8 to 30 C atoms or residues of dimerization products of these fatty alcohols.
  • the addition of such mixed esters a particularly pleasant feeling on the skin is achieved in the application of the body cleanser.
  • the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
  • compositions according to the invention may preferably contain at least one nonionic emulsifier having an HLB value of 8 to 18.
  • Nonionic emulsifiers having an HLB value of 10 to 15 may be particularly preferred according to the invention.
  • Emulsifiers preferred according to the invention are the so-called mild emulsifiers.
  • the mildness of emulsifiers can be determined by various methods. For example, the neutral red test, the HET-CAM test, the human skin model or the so-called BUS (bovine udder skin) model are used for this purpose. What is common to all test methods is that it is principally measured against a standard to which the results are referred. Furthermore, it is pointed out that in The chapter "Surfactants" has already described in detail how to select mild raw materials, as well as the selection of mild emulsifiers.
  • Sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C atoms in the alkyl group and sulfosuccinic acid monoalkyl polyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups,
  • Esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 C atoms,
  • Polyol fatty acid esters such as the commercially available product ® Hydagen HSP (Cognis) or Sovermol ® - types (Cognis),
  • Hydroxymix ethers for example of the formula
  • R 1 O [CH 2 CH (CH 3 ) O] x (CH 2 CHR 2 O) y [CH 2 CH (OH) R 3 ] z with R 1 being a linear or branched, saturated or unsaturated alkyl and / or or alkenyl radical having 2 to 30 C atoms, R 2 is hydrogen, a methyl, ethyl, propyl or iso-propyl radical, R 3 is a linear or branched alkyl radical having 2 to 30 C atoms, x is 0 or a number from 1 to 20, Y stands for a number from 1 to 30 and z stands for the number 1, 2, 3, 4 or 5.
  • Alkylamidoamines and quaternized alkylamidoamines are quaternized alkylamidoamines.
  • alkyl (oligo) glucosides for example, the commercially available product ® Montanov 68,
  • Partial esters of polyols having 3-6 carbon atoms with saturated fatty acids having 8 to 22 carbon atoms, - Sterols, Sterols is a group of steroids that carry a hydroxyl group at C-atom 3 of the steroid skeleton and are isolated from animal tissue (zoosterols) as well as vegetable fats (phytosterols).
  • zoosterols are cholesterol and lanosterol.
  • suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
  • glucose phospholipids e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol
  • Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hy- droxystearat (Dehymuls ® PGPH commercial product)
  • the particularly mild emulsifiers are preferably used in the compositions.
  • the alkyl sulfates and / or alkyl ether sulfates are used in amounts of less than 8% by weight, preferably less than 5% by weight and more preferably less than 2.5% by weight.
  • these compositions are free of alkyl sulfates and / or alkyl ether sulfates.
  • Free from in this context means that these ingredients are not used in any way, but it is possible that they may be introduced into the composition by other ingredients, such as the use of silicone emulsions, so “free from” preferably means smaller than 0.5% by weight, more preferably less than 0.1% by weight.
  • phase inversion temperature depends on many factors, for example the type and phase volume of the oil component, of the hydrophilicity and the structure of the emulsifier or the composition of the emulsifier system.
  • Emulsions prepared at or slightly below the phase inversion temperature are characterized by particular stability and fineness, while those prepared above the phase inversion temperature are less finely divided.
  • Emulsions that undergo phase inversion at a certain temperature are called PIT emulsions.
  • PIT emulsions may be preferred according to the invention, because they contain significantly less emulsifier than conventional non-PIT emulsions due to the just sufficient amount of emulsifier. Therefore, they are not only particularly inexpensive, but also very mild and gentle on the skin and hair. If ionic surfactants are also used as emulsifiers in the PIT emulsions, these are added to the PIT emulsion more preferably only after the preparation of the PIT emulsion during the cooling process.
  • Very particular cationic and amphoteric and / or zwitterionic polymers are used in the combination of active substances according to the invention as further compulsory ingredients.
  • Polymers are used in cosmetic compositions for a variety of reasons. In this case, nonionic polymers are used.
  • Cationic polymers are polymers which have a group in the main and / or side chain which is “temporary” or “permanent”. can be cationic.
  • "permanently cationic” refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group.
  • Preferred cationic groups are quaternary ammonium groups.
  • those polymers in which the quaternary ammonium group is bonded via a C 1-4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.
  • cationic polymers according to the invention are the so-called “temporary cationic" polymers, which usually contain an amino group which, at certain pH values, is present as a quaternary ammonium group and thus cationically.
  • the cationic polymers according to the invention can be both firming and / or film-forming and / or antistatic and / or scavenging polymers as well as polymers with conditioning and / or thickening properties.
  • the suitable cationic polymers are preferably fixing and / or conditioning polymers.
  • polymers are meant both natural and synthetic polymers which may be cationic or amphoteric charged.
  • Both cationic and amphoteric or zwitterionic polymers can therefore be characterized by their cationic charge density.
  • the polymers of the invention are characterized by a charge density of at least 1 to 7 meq / g.
  • a charge density of at least 2 to 7 meq / g is preferred.
  • Particularly preferred is a charge density of at least equal to 3meq / g to 7 meq / g.
  • the molecular weight of the particular polymer is understood to mean the molecular weight which the manufacturer indicates in the corresponding data sheets by its method.
  • a suitable polymer has a Molar mass of at least 50,000 g / u proved to be suitable according to the invention.
  • Polymers with a molecular weight of more than 100,000 g / u have proven to be particularly suitable.
  • Polymers with a molecular weight of more than 1,000,000 g / u are particularly suitable.
  • Suitable polymers have a value of greater than 100,000 for the product of cationic charge density and molecular weight. Particularly suitable are polymers which have a value of at least 200,000 for this product. Especially suitable are those polymers in which this product has a value greater than 250,000. Most suitable are those polymers in which this product has a value of at least 1,000,000.
  • the cationic polymers may be homo- or copolymers, wherein the quaternary nitrogen groups either in the polymer chain or preferably as a substituent one or more of the monomers are included.
  • the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
  • Suitable cationic monomers are unsaturated, free-radically polymerizable compounds which carry at least one cationic group, in particular ammonium-substituted vinyl monomers such as trialkylmethacryloxyalkyl ammonium, trialkylacryloxyalkylammonium, dialkyldiallylammonium and quaternary vinylammonium monomers having cyclic, cationic nitrogen-containing groups such as pyridinium, imidazolium or quaternary pyrrolidones, for example alkylvinylimidazolium , Alkylvinylpyridinium, or Alyklvinylpyrrolidon salts.
  • the alkyl groups of these monomers are preferably lower alkyl groups such as C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.
  • the ammonium group-containing monomers may be copolymerized with non-cationic monomers.
  • Suitable comonomers are, for example, acrylamide, methacrylamide; Alkyl and dialkylacrylamide, alkyl and dialkylmethacrylamide, alkylacrylate, alkylmethacrylate, vinylcaprolactone, vinylcaprolactam, vinylpyrrolidone, vinylester, e.g. Vinyl acetate, vinyl alcohol, propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers are preferably C1 to C7 alkyl groups, more preferably C1 to C3 alkyl groups.
  • suitable polymers having quaternary amine groups are the polymers described in the CTFA Cosmetic Ingredient Dictionary under the names Polyquaternium, such as methylvinylimidazolium chloride A / inylpyrrolidone copolymer (Polyquaternium-16) or quaternized vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer (Polyquaternium-1 1), and quaternary silicone polymers or oligomers, for example Silicone polymers with quaternary end groups (Quaternium-80).
  • Polyquaternium such as methylvinylimidazolium chloride A / inylpyrrolidone copolymer (Polyquaternium-16) or quaternized vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer (Polyquaternium-1 1)
  • quaternary silicone polymers or oligomers for example Silicone polymers with quaternary end groups (Quatern
  • cationic polymers for example vinylpyrrolidone / dimethylaminoethyl copolymer available under the trade names Gafquat ® 755 N and Gafquat ® 734, United States is marketed by Gaf Co. and of which the Gafquat ® 734 is particularly preferred suitable.
  • cationic polymers are for example marketed by BASF, Germany under the trade name Luviquat.RTM ® HM 550 Copolymer of polyvinyl pyrrolidone and imidazolimine which ® by the company Calgon / USA under the trade name Merquat Plus 3300 sold terpolymer of dimethyl diallyl ammonium chloride, sodium acrylate and acrylamide and the product sold by the company ISP under the trade name Gafquat ® HS 100 vinylpyrrolidone / methacrylic amidopropyltrimethylammoniumchlorid copolymer.
  • R 1 -H or -CH 3
  • R 2 , R 3 and R 4 are independently selected from C 1-4 -alkyl, -alkenyl or -hydroxyalkyl groups
  • m 1, 2, 3 or 4
  • n is a natural number
  • X is a physiologically acceptable organic or inorganic anion
  • copolymers consisting essentially of the monomer units listed in formula (G1-I) and nonionic monomer units are particularly preferred cationic polymers preferably, for which at least one of the following conditions applies:
  • R 1 is a methyl group
  • R 2 , R 3 and R 4 are methyl groups m has the value 2.
  • Suitable physiologically acceptable counter ions X include halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions. Preferred are halide ions, particularly chloride.
  • a particularly suitable homopolymer is, if desired, crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37.
  • Such products are, for example, under the names Rheocare ® CTH (Cosmetic Rheologies) and Synthalen® ® CR (3V Sigma) in trade available.
  • the crosslinking can, if desired, be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
  • Methylenebisacrylamide is a preferred crosslinking agent.
  • the homopolymer is preferably used in the form of a nonaqueous polymer dispersion which should not have a polymer content of less than 30% by weight.
  • Such polymer dispersions are (under the names Salcare ® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1-Trideceth- 6)), and Salcare ® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol with a mixture of caprylic and capric acid (INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene polyoxyethylene ether (INCI name: PPG-1-Trideceth-6)) commercially available.
  • Copolymers with monomer units of the formula (G1-I) as the non-ionic monomer preferably acrylamide, methacrylamide, acrylic acid-Ci -4 alkyl ester and methacrylic acid-Ci- 4 -alkyl.
  • the acrylamide is particularly preferred.
  • These copolymers can also be crosslinked, as described above in the case of the homopolymers.
  • a copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer.
  • Such copolymers in which the monomers are present in a weight ratio of about 20:80 are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ® SC.
  • Suitable cationic silicone compounds preferably have either at least one amino group or at least one ammonium group.
  • Suitable silicone polymers with amino groups are known under the INCI name Amodimethicone. These are polydimethylsiloxanes with aminoalkyl groups. The aminoalkyl groups may be side or terminal.
  • the N-containing silicone as cationic polymer according to the invention can preferably be selected from the group comprising siloxane polymers having at least one amino group, Siloxane polymers having at least one terminal amino group, amodimethicone, trimethylsilylamodimethicone, and / or aminoethylaminopropylsiloxane-dimethylsiloxane copolymer.
  • Suitable silicone polymers having two terminal quaternary ammonium groups are known by the INCI name Quaternium-80. These are dimethylsiloxanes having two terminal aminoalkyl groups.
  • Preferred according to the invention is the use of an aminosiloxane according to the following general formula (G 1-11),
  • R OH or CH 3
  • Emulsions which can preferably be used according to the invention are Dow Corning® 949, which is a cationic emulsion comprising amodimethicone, cetrimonium chloride and trideceth-12; Dow Corning® 939, which is an emulsion containing amodimethicone, cetrimonium chloride and trideceth-12; Dow Corning® 929, which is a cationic emulsion containing amodimethicone, talc trimonium chloride and nonoxynol-10; Dow Corning® 7224 or 1401 based on trimethylsilylamodimethicone, octoxynol-40, isolaureth-6 and glycol; Dow Corning® 2-8194 microemulsion (26%) based on an amine-functionalized silicone polymer; Dow Corning® 2-8177 microemulsion (12%) based on
  • the molecular weight of the aminosilicones is preferably between 500 and 100,000.
  • the amine content (meq / g) is preferably in the range from 0.05 to 2.3, more preferably from 01 to 0.5.
  • the silicone as a cationic polymer according to the invention is used in an amount of 0.01 to 20% by weight, based on the total agent, preferably in amounts of 0.05 to 15% by weight and very particularly preferably in amounts of 0.05 to 10% by weight .% used.
  • Suitable cationic polymers derived from natural polymers are cationic derivatives of polysaccharides, for example cationic derivatives of
  • Cellulose, starch or guar are also suitable.
  • chitosan and chitosan derivatives are also suitable.
  • Cationic polysaccharides have the general formula (G1-III) GOB-N + R a R b R c X "
  • G is an anhydroglucose residue, for example starch or cellulose anhydroglucose
  • B is a divalent linking group, for example alkylene, oxyalkylene,
  • R 3 , R b and R c are independently alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl or alkoxyaryl each having up to 18 carbon atoms, wherein the total number of C atoms in
  • R 3 , Rb and R c is preferably at most 20;
  • X " is a common counteranion and is preferably chloride.
  • a cationic cellulose is sold under the name Polymer JR 400 from Amerchol ® and has the INCI designation Polyquaternium-10 degrees.
  • Another cationic cellulose bears the INCI name Polyquaternium-24 and is sold under the trade name Polymer LM-200 by Amerchol.
  • Other commercial products are the compounds Celquat ® H 100, Celquat ® L and 200. The commercial products mentioned are preferred cationic celluloses.
  • Suitable cationic guar derivatives are marketed under the trade name Jaguar ® and have the INCI name guar hydroxypropyltrimonium chloride. Furthermore, particularly suitable cationic guar derivatives are also from the Fa. Hercules under the name N-Hance ® in the trade. Other cationic guar derivatives are marketed by the company. Cognis under the name Cosmedia® ®. A preferred cationic guar derivative is the commercial product AquaCat® ® from. Hercules. This raw material is an already pre-dissolved cationic guar derivative.
  • hydrocolloids of the chitosan type are partially deacetylated chitins of different molecular weight, which contain the - idealized - monomer unit (I):
  • chitosans are cationic biopolymers under these conditions.
  • the positively charged chitosans can interact with oppositely charged surfaces and are therefore used in cosmetic hair and body care products as a film former.
  • the chitosans are also quaternized, alkylated and / or hydroxyalkylated derivatives, optionally also in microcrystalline form into consideration.
  • the insert can also be in the form of aqueous gels having a solids content in the range of 1 to 5 wt .-%.
  • chitosans For the production of chitosans is based on chitin, preferably the shell remains of crustaceans, which are available as inexpensive raw materials in large quantities.
  • the chitin is usually first deproteinized by the addition of bases, demineralized by the addition of mineral acids and finally deacetylated by the addition of strong bases, wherein the molecular weights can be distributed over a broad spectrum.
  • particularly low-ash cationic biopolymers are used which are obtained by reacting
  • the chitosans to be used according to the invention are completely or partially deacetylated chitins.
  • the molecular weight of the chitosan can be distributed over a broad spectrum, for example from 20,000 to about 5 million g / mol.
  • a low molecular weight chitosan having a molecular weight of from 30,000 to 70,000 g / mol is suitable.
  • the molecular weight is above 100,000 g / mol, more preferably from 200,000 to 700,000 g / mol.
  • the degree of deacetylation is preferably 10 to 99%, more preferably 60 to 99%.
  • the chitosans or chitosan derivatives are preferably in neutralized or partially neutralized form.
  • the degree of neutralization of the chitosan or the chitosan derivative is preferably at least 50%, more preferably between 70 and 100%, based on the number of free base groups.
  • neutralizing agents it is possible in principle to use all cosmetically acceptable inorganic or organic acids, such as, for example, formic acid, tartaric acid, malic acid, lactic acid, citric acid, pyrrolidonecarboxylic acid, hydrochloric acid, among others, of which the pyrrolidonecarboxylic acid is particularly preferred.
  • a suitable chitosan is sold, for example, by Kyowa Oil & Fat, Japan under the trade name Flonac ®. It has a molecular weight of 300,000 to 700,000 g / mol and is deacetylated to 70 to 80%.
  • a preferred chitosan is chitosoniumpyrrolidone is, for example, sold under the name Kytamer ® PC by Amerchol, USA. The contained chitosan has a molecular weight of about 200,000 to 300,000 g / mol and is deacetylated to 70 to 85%.
  • Suitable chitosan derivatives are quaternized, alkylated or hydroxyalkylated derivatives, for example hydroxyethyl or hydroxybutylchitosan. Further chitosan derivatives are Hydagen® ® CMF, Hydagen® ® HCMF and Chitolam ® NB / 101 freely available under the trade names in the trade.
  • quaternized cellulose derivatives such as are available under the names of Celquat ® and Polymer JR ® commercially.
  • the compounds Celquat ® H 100, Celquat ® L 200 and Polymer JR ® 400 are preferred quaternized cellulose derivatives, cationic alkyl polyglycosides according to DE-PS 44 13 686, cationized honey, for example the commercial product Honeyquat ® 50, cationic guar derivatives, such as in particular the products sold under the trade names Cosme- dia ® guar and Jaguar ® products, polymeric dimethyldiallylammonium salts and their copolymers with esters and amines of the acrylic acid and methacrylic acid.
  • Copolymers of vinylpyrrolidone with quaternized derivatives of dialkylaminoalkyl acrylate and methacrylate such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers.
  • Such compounds are sold under the names Gafquat ® 734 and Gafquat ® 755 commercially, - vinylpyrrolidone vinylimidazoliummethochloride copolymers, such as those offered under the names Luviquat.RTM ® FC 370, FC 550, FC 905 and HM 552,
  • polyquaternized polyvinyl alcohol as well as the polymers known as polyquaternium 2, polyquaternium 17, polyquaternium 18 and polyquaternium 27 with quaternary nitrogen atoms in the polymer main chain,
  • Vinylpyrrolidone-vinylcaprolactam-acrylate terpolymers such as those offered with acrylic acid esters and acrylamides as the third monomer building commercially, for example, under the name Aquaflex ® SF 40.
  • Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ® LM 200), known polymers.
  • copolymers of vinylpyrrolidone such as the commercial products Copolymer 845 (manufactured by ISP), Gaffix ® VC 713 (manufactured by ISP), Gafquat ® ASCP 101 1, Gafquat ® HS 110, Luviquat ® 8155 and Luviquat ® MS 370 are available.
  • cationic polymers which can be used in the compositions according to the invention are the so-called "temporary cationic" polymers. These polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic.
  • temporary cationic polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic.
  • chitosan and its derivatives are preferred as Hydagen CMF ®, Hydagen HCMF ®, Kytamer ® PC and Chitolam ® NB / 101 are freely available commercially, for example under the trade names.
  • preferred cationic polymers are cationic cellulose derivatives and chitosan and its derivatives, in particular the commercial products Polymer ® JR 400, Hydagen ® HCMF and Kytamer ® PC, cationic guar derivatives, cationic honey derivatives, in particular the commercial product Honeyquat ® 50, cationic Alkylpolyglycodside according to DE-PS 44 13 686 and polymers of the type Polyquaternium-37.
  • cationized protein hydrolyzates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates.
  • the protein hydrolyzates on which the cationic derivatives according to the invention are based can be obtained from the corresponding proteins by chemical, in particular alkaline or acid hydrolysis, by enzymatic hydrolysis and / or a combination of both types of hydrolysis.
  • cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof.
  • the quaternization of the protein hydrolyzates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides.
  • the cationic protein hydrolysates may also be further derivatized.
  • the cationic protein hydrolysates and derivatives according to the invention those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry and Fragrance Association 1 101 17 th Street, NW, Suite 300, Washington, DC 20036-4702) and commercially available products called: Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / My
  • the cationic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the anionic polymers (G2) are anionic polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as sole or co-monomer have proven to be particularly effective Sulfonic acid group may be wholly or partially present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • the homopolymer of 2-acrylamido-2-methylpropanesulfonic acid is, which is 1 1-80 commercially available, for example under the name Rheothik ®.
  • copolymers of at least one anionic monomer and at least one nonionic monomer are preferable to use copolymers of at least one anionic monomer and at least one nonionic monomer.
  • anionic monomers reference is made to the substances listed above.
  • Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers.
  • a particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt is present.
  • This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used.
  • crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylene-bisacrylamide are used.
  • Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • Simulgel ® 600 as a compound with isohexadecane and polysorbate-80 Natriumacryloyldimethyltaurat copolymers have proved to be particularly effective according to the invention.
  • preferred anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially.
  • Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers.
  • a 1, 9-decadiene cross-linked methyl vinyl ether-maleic acid copolymer is available under the name ® Stabileze QM.
  • the anionic polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • polyurethanes consist of at least two different monomer types, a compound (V1) having at least 2 active hydrogen atoms per molecule and a di- or polyisocyanate (V2).
  • the compounds (V1) may be, for example, diols, triols, diamines, triamines, polyetherols and polyesterols.
  • the compounds having more than 2 active hydrogen atoms are usually used only in small amounts in combination with a large excess of compounds with 2 active hydrogen atoms.
  • Examples of compounds (V1) are ethylene glycol, 1, 2 and 1, 3-propylene glycol, butylene glycols, di-, tri-, tetra- and poly-ethylene and -Propylenglykole, copolymers of lower alkylene oxides such as ethylene oxide, propylene oxide and butylene oxide, Ethylenediamine, propylenediamine, 1, 4-diaminobutane, hexamethylenediamine and, diamines based on long-chain alkanes or polyalkylene oxides.
  • Polyurethanes in which the compounds (V1) are diols, triols and polyetherols may be preferred according to the invention.
  • polyethylene glycols and polypropylene glycols having molecular weights between 200 and 3000, in particular between 1600 and 2500, have proven to be particularly suitable in individual cases.
  • Polyesterols are usually obtained by modifying the compound (V1) with dicarboxylic acids such as phthalic acid, isophthalic acid and adipic acid.
  • polyurethanes used in the invention may contain other building blocks such as diamines as chain extenders and hydroxycarboxylic acids.
  • Dialkylolcarboxylic acids such as dimethylolpropionic acid are particularly suitable hydroxycarboxylic acids.
  • further building blocks there is no fundamental restriction as to whether they are nonionic, anionic or cationic building blocks.
  • compositions according to the invention when the polyurethanes were not mixed directly with the other components, but introduced in the form of aqueous dispersions.
  • Such dispersions usually have a solids content of about 20-50%, in particular about 35-45% and are also commercially available.
  • amphoteric polymers can be used as polymers.
  • amphoteric polymers both those polymers which contain both free amino groups and free -COOH or SO ß H groups in the molecule and are capable of forming inner salts, but also zwitterionic polymers containing quaternary ammonium groups in the molecule and -COO contain " - or -SO ß ' groups, and summarized those polymers containing -COOH or SO 3 H groups and quaternary ammonium groups.
  • Amphoteric polymers like the cationic polymers, are most preferred polymers.
  • amphopolymer suitable is the acrylic resin commercially available as Amphomer ®, ethyl methacrylate, a copolymer of tert-butylamino, N- (1, 1, 3,3-tetramethylbutyl) -acrylamide and two or more monomers from the group Acrylic acid, methacrylic acid and their simple esters.
  • amphoteric polymers are those polymers which are composed essentially
  • R 1 -CH CR 2 -CO-Z- (C n H 2n ) -N (+) R 3 R 4 R 5 A H (G3-I) in which R 1 and R 2 independently of one another are hydrogen or a methyl group and R 3 , R 4 and R 5 independently of one another are alkyl groups having 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer from 2 to 5 and A H is the anion of an organic or inorganic acid, and
  • R 6 and R 7 are independently hydrogen or methyl groups.
  • These compounds can be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention.
  • Very particular preference is given to those polymers in which monomers of the type (a) are used in which R 3 , R 4 and R 5 are methyl groups, Z is an NH group and A H is a halide, methoxysulfate or ethoxysulfate ion ;
  • Acrylamidopropyl trimethyl ammonium chloride is a particularly preferred monomer (a).
  • Acrylic acid is preferably used as monomer (b) for the stated polymers.
  • Suitable starting monomers are, for. Dimethylaminoethylacrylamide, dimethylaminoethylmethacrylamide, dimethylaminopropylacrylamide, dimethylaminopropylmethacrylamide and diethylaminoethylacrylamide when Z represents an NH group or dimethylaminoethyl acrylate, dimethylaminoethyl methacrylate and
  • the monomers containing a tertiary amino group are then quaternized in a known manner, methyl chloride, dimethyl sulfate or diethyl sulfate being particularly suitable as alkylating reagents.
  • the quaternization reaction can be carried out in aqueous solution or in the solvent.
  • those monomers of the formula (G3-I) are used which are derivatives of acrylamide or methacrylamide. Further preferred are those Monomers containing as counter ions halide, methoxysulfate or ethoxysulfate ions. Also preferred are those monomers of formula (G3-I) wherein R3, R4 and R5 are methyl groups.
  • the acrylamidopropyltrimethylammonium chloride is a most preferred monomer of the formula (G3-I).
  • Suitable monomeric carboxylic acids of the formula (G3-II) are acrylic acid, methacrylic acid, crotonic acid and 2-methylcrotonic acid. Preference is given to using acrylic or methacrylic acid, in particular acrylic acid.
  • the zwitterionic polymers which can be used according to the invention are prepared from monomers of the formulas (G3-I) and (G3-II) by polymerization processes known per se. Further details of the polymerization process can be found in the relevant specialist literature.
  • amphoteric polymers are preferably contained in the agents according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • Further amphoteric polymers which can be used according to the invention are the compounds mentioned in British Patent Application 2,104,091, European Patent Application 47,714, European Offenlegungsschrift 217,274, European Offenlegungsschrift 283,817 and German Offenlegungsschrift 28 17 369.
  • Further suitable zwitterionic polymers are Methacroylethylbetain / methacrylate copolymers, which are commercially available under the name Amersette ® (AMERCHOL).
  • the agents according to the invention may contain nonionic polymers (G4).
  • Suitable nonionic polymers are, for example:
  • Vinylpyrrolidone / vinyl ester copolymers as sold, for example, under the trademark Luviskol ® (BASF).
  • Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy-, as sold for example under the trademark Culminal® ® and Benecel ® (AQUALON) and Natrosol ® grades (Hercules).
  • Starch and its derivatives in particular starch, such as Structure XL ® (National Starch), a multifunctional, salt-tolerant starch; shellac
  • Siloxanes These siloxanes can be both water-soluble and water-insoluble. Both volatile and nonvolatile siloxanes are suitable, nonvolatile siloxanes being understood as meaning those compounds whose boiling point is above 200 ° C. under normal pressure.
  • Preferred siloxanes are polydi- alkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups.
  • the nonionic polymers are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • the term polymer also means special preparations of polymers, such as spherical polymer powders.
  • polymers such as spherical polymer powders.
  • Suitable polymers are, for example, polycarbonates, polyurethanes, polyacrylates, polyolefins, polyesters or polyamides.
  • Particularly suitable are those spherical polymer powders whose primary particle diameter is less than 1 micron.
  • Such products based on a polymethacrylate copolymer are, for example, under the trade name Polytrap ® Q5-6603 (Dow Corning) in the trade.
  • Other polymer powders for example based on polyamides (nylon 6, nylon 12) having a particle size of 2 - (10 microns (90%) and a specific surface area of about 10 m 2 / g under the trade name Orgasol ® 2002 DU Nat Cos Atochem SA, Paris).
  • spherical polymer powders which are suitable for the purpose according to the invention are, for example, the polymethacrylates (Micropearl M) from SEPPIC or (Plastic Powder A) from NIKKOL, the styrene-divinylbenzene copolymers (Plastic Powder FP) from NIKKOL, the polyethylene and polypropylene Powder (ACCUREL EP 400) from AKZO, or else silicone polymers (Silicone Powder X2-1605) from Dow Corning or even spherical cellulose powders.
  • the polymethacrylates (Micropearl M) from SEPPIC or (Plastic Powder A) from NIKKOL
  • Plastic Powder FP styrene-divinylbenzene copolymers
  • ACCUREL EP 400 polyethylene and polypropylene Powder
  • silicone polymers Silicone Powder X2-1605
  • the polymer powders described above are preferably contained in the compositions according to the invention in amounts of from 0.05 to 10% by weight, based on the total composition. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • Polymers regardless of their chemical structure and charge, can also be characterized by their function in cosmetic compositions.
  • the description of the polymers according to their function in the compositions according to the invention does not necessarily correspond to an evaluation or significance of these polymers. Rather, all polymers are in principle to be considered equivalent for use in the compositions of the invention, although some of these polymers may be preferred.
  • some polymers can be found in several descriptions with different effects. Polymers which have several desired effects Accordingly, they are particularly preferred for use in the compositions of the invention.
  • the choice of the suitable polymer also depends on the use of the composition according to the invention.
  • Film-forming polymers are polymers which leave a continuous film on the skin, the hair or the nails when drying.
  • Such film formers can be used in a wide variety of cosmetic products, such as for example face masks, make-up, hair fixatives, hair sprays, hair gels, hair waxes, hair treatments, shampoos or nail varnishes.
  • Particular preference is given to those polymers which have sufficient solubility in alcohol or water / alcohol mixtures to be present in completely completely dissolved form in the composition according to the invention. Because of their pronounced film formation properties, these polymers are very particularly preferred in the compositions of the invention. The use of at least one of these polymers is therefore also very particularly preferred according to the invention.
  • the film-forming polymers may be of synthetic or natural origin.
  • film-forming polymers are also understood to mean those polymers which, when used in 0.01 to 20% strength aqueous, alcoholic or aqueous-alcoholic solution, are capable of depositing a transparent polymer film on the skin or on the hair.
  • the film-forming polymers can thereby both anionic, amphoteric, nonionic, permanent cationic or temporarily cationically charged.
  • Suitable synthetic, film-forming, setting polymers are homopolymers or copolymers made up of at least one of the following monomers: vinylpyrrolidone, vinylcaprolactam, vinyl esters, e.g. Vinyl acetate, vinyl alcohol, acrylamide, methacrylamide, alkyl and dialkylacrylamide, alkyl and dialkylmethacrylamide, alkyl acrylate, alkyl methacrylate, propylene glycol or ethylene glycol, wherein the alkyl groups of these monomers are preferably C1 to C7 alkyl groups, particularly preferably C1 to C3 alkyl groups.
  • Suitable examples are homopolymers of vinylcaprolactam, vinylpyrrolidone or N-vinylformamide.
  • Further suitable synthetic film-forming fixing polymers are copolymers of vinyl pyrrolidone and vinyl acetate, terpolymers of vinylpyrrolidone, vinyl acetate and vinyl propionate, polyacrylamides, for example, under the trade designations Akypomine ® P 191 by the company CHEM-Y, Emmerich or Sepigel ® 305 by the company Seppic be distributed; Polyvinyl alcohols, which are marketed under the trade names Elvanol.RTM ® from DuPont or Vinol ® 523/540 by Air Products as well as polyethylene glycol / polypropylene glycol copolymers, for example, sold under the trade names Ucon® Union Carbide. Particularly preferred are polyvinylpyrrolidone and polyvinylpyrrolidone / vinyl acetate copolymers.
  • Suitable natural film-forming polymers include cellulose derivatives, eg. B. hydroxypropyl cellulose having a molecular weight of 30,000 to 50,000 g / mol, which is sold, for example, under the trade name Nisso Sl ® from Lehmann & Voss, Hamburg.
  • Examples of common film formers are Abies Balsamea (Balsam Canada) Resin, Acetylenediurea / Formaldehyde / Tosylamide Crosspolymer, Acrylamide / Ammonium Acrylate Copolymer, Acrylamide Copolymer, Acrylamide / DMAPA Acrylates / Methoxy PEG Methacrylate Copolymer, Acrylamide / Sodium Acrylate Copolymer, Acrylamidopropyltrimonium Chloride / Acrylamide Copolymer , Acrylamidopropyltrimonium Chloride / Acrylates Copolymer, Acrylates / Acetoacetoxyethyl Methacrylate Copolymer, Acrylates / Acrylamide Copolymer, Acrylates / Ammonium Methacrylate Copolymer, Acrylates / Behenyl Methacrylates / Dimethicone Methacrylate Copolymer, Acrylates /
  • Aminoethylpropanediol-AMPD Acrylates / Diacetone Acrylamide Copolymer, Ammonium Acrylates / Acrylonitrogen Copolymer, Ammonium Acrylates Copolymer, Ammonium Alginates, Ammonium Polyacrylates, Ammonium Styrene / Acrylates Copolymer, Ammonium VA / Acrylates Copolymer, AMPD Acrylates / Diacetone Acrylamide Copolymer, AMP Acrylates / Allyl Methacrylates Copolymer, AMP Acrylates / C1-18 Alkyl Acrylates / C1-8 Alkyl Acrylamide Copolymer, AMP Acrylates Copolymer, AMP Acrylates Copolymer, AMP Acrylates / Diacetone Acrylamide Copolymer, AMP Acrylates / Dimethylaminoethyl Methacrylate Copolymer, Astragalus Gummifer Gum, Avena Sativa
  • Polyquaternium-1 Polyquaternium-2, Polyquaternium-4, Polyquaternium-5,
  • Polyquaternium-10 Polyquaternium-1 1, Polyquaternium-12, Polyquaternium-13,
  • Trimethylsiloxysilicate / Dimethiconol Crosspolymer Trimethylsiloxysilylcarbamoyl Pullulan, Triticum Vulgaris (Wheat) Protein, Tromethamine Acrylates / Acrylonitrogen Copolymer, VA / Butyl Maleate / Isobornyl Acrylate Copolymer, VA / Crotonates Copolymer, VA / Crotonates / Methacryloxybenzophenone-1 Copolymer, VA / CrotonatesA / inyl
  • Neodecanoate Copolymer VA / Crotonates A / inyl Propionate Copolymer, VA / Crotonic Acid / PEG-20M Copolymer, VA / DBM Copolymer, VA / Isobutyl MaleateA / inyl Neodecanoate Copolymer, VAA / inyl Butyl Benzoate / Crotonates Copolymer, VAA / inyl Chloride Copolymer, Vinyl Acetates, Vinylamines / Vinyl Alcohol Copolymer, Vinyl Caprolactam A / P / Dimethylaminoethyl Methacrylate Copolymer, Vinyl Chloride A / inyl Laurate Copolymer, VP / Dimethicone Acrylates / Polycarbamyl / Polyglycol Ester, VP / Dimethylaminoethyl Methacrylate Copolymer,
  • the antistatic effect of polymers is another essential function for cosmetic agents.
  • the surfaces of the cosmetically treated substrates skin, nails and keratinic fibers are influenced in their electrical potential.
  • this effect reduces the effect known as "fly-away effect” and is based on the electrostatic repulsion of the hair fibers, but it also affects the skin surface on the skin surface, and some of these polymers have their optimum effect
  • preference is given from this group of polymers to those which at the same time belong to at least one of the groups of fixing and / or film-forming polymers
  • antistatic polymers examples include:
  • the emulsion-stabilizing polymers are also among the polymers preferred according to the invention. These are understood to mean polymers which essentially support the structure and the stabilization of emulsions (O / W and W / O as well as multiple emulsions). Surfactants and emulsifiers are of course the essential ingredients, but the stabilizing polymers contribute to a reduction in the coalescence of the emulsified droplets by positively affecting the continuous or disperse phase. This positive influence may be due to an electrical repulsion, an increase in viscosity or a film formation on the surface of the droplets. These properties of the polymers in question can also be used to particular advantage in the compositions according to the invention in order to dissolve the powdery compositions according to the invention before and / or during the application of the powder in water.
  • Examples of such polymers are Acrylamide / Sodium Acryloyl Dimethyl Taurate Copolymer, Acrylates / Amino Acrylates / CIO-30 Alkyl PEG-20 Itaconate Copolymer, Acrylates / C10-30 Alkyl Acrylate Crosspolymer, Acrylates / Stearyl Methacrylate Copolymer, Acrylates / Vinyl Isodecanoate Crosspolymer, Alcaligenes Polysaccharides, AIIyI Methacrylate Crosspolymer, Ammonium Acryloyldimethyltaurate / Beheneth-25 Methacrylate Crosspolymer, Ammonium Acryloyldimethyltaurate / Vinyl Formamide Copolymer, Ammonium Alginate, Ammonium Phosphatidyl Rapeseedate, Ammonium Polyacrylate, Ammonium Polyacryloyldimethyl Taurate, Ammonium Shellacate, Arachidyl Alcohol, Astragalus Gummifer
  • Polymers can increase the viscosity of aqueous and non-aqueous phases in cosmetic preparations.
  • aqueous phases their viscosity-increasing function is based on their solubility in water or their hydrophilic nature. They are used in both surfactant and emulsion systems. This property of the polymers is also advantageous in the compositions according to the invention before and / or during use.
  • Acrylamide Copolymer Acrylamide / Sodium Acrylate Copolymer, Acrylamide / Sodium Acryloyl Dimethyl Taurate Copolymer, Acrylates / Acetoacetoxyethyl Methacrylate Copolymer, Acrylates / Beheneth-25 Methacrylate Copolymer, Acrylates / C 10-30 Alkyl Acrylate Crosspolymer, Acrylates / Ceteth-20 Itaconate Copolymer, Acrylates / Ceteth -20 Methacrylate Copolymer, Acrylates / Laureth-25 Methacrylate Copolymer, Acrylates / Palmeth-25 Acrylate Copolymer, Acrylates / Palmeth-25 Itaconate Copolymer, Acrylates / Steareth-50 Acrylate Copolymer, Acrylates / Steareth-20 Itaconate Copolymer, Acrylates / Steareth-20 Methacrylate Copolymer, Acrylates / Steary
  • Acryloyldimethyltaurate / VP Copolymer Ammonium Alginate, Ammonium Polyacryloyldimethyl Taurate, Amylopectin, Ascorbyl Methylsilanol Pectinate, Astragalus Gummifer Gum, Attapulgite, Avena Sativa (Oat) Kernel Flour, Bentonite, Butoxy Chitosan, Caesalpinia Spinosa Gum, Calcium Alginate, Calcium Carboxymethyl Cellulose, Calcium Carrageenan , Calcium Potassium Carbomer, Calcium Starch Octenylsuccinate, C20-40 Alkyl Stearate, Carbomer, Carboxybutyl Chitosan, Carboxymethyl Chitin, Carboxymethyl Chitosan, Carboxymethyl Dextran, Carboxymethyl Hydroxyethylcellulose, Carboxymethyl Hydroxypropyl Guar, Cellulose Acetate Propionate Carboxylate, Cellulose Gum
  • Another way to increase the viscosity of cosmetic products is the thickening of the non-aqueous phase, the lipid phase of the cosmetic products.
  • polymers are used which are not water-soluble but compatible with lipids. They are also used for the gelation of cosmetic products with high lipid levels. This also contributes significantly to the excellent application of the agents according to the invention.
  • Divinyl Dimethicone / Dimethicone Crosspolymer Dodecanedioic Acid / Cetearyl Alcohol / Glycol Copolymer, Ethyl Cellulose, Ethylene / Acrylic Acid Copolymer, Ethylene / Acrylic Acid A / A Copolymer, Ethylenediamine / Dimer Tallate Copolymer Bis-Hydrogenated Tallow Amide, Ethylene Diamine / Stearyl Dimer Dilinoleate Copolymer, Ethylene Diamine / Stearyl Dimer Tallate Copolymer, Ethylene / Octene Copolymer, Ethylene / Propylene Copolymer, Ethylene / Propylene / Styrene Copolymer, Euphorbia Cerifera (Candelilla) Wax, Hydrogenated Butylene / Ethylene / Styrene Copolymer, Hydrogenated Ethylene / Prop
  • microparticles filled or unfilled may also be used in the composition of the invention both to achieve certain effects, such as the release of an active agent from the capsules or the achievement of particular visual, esthetic effects of the overall formulation.
  • Suspension aids facilitate the distribution of solids in liquids.
  • the polymers occupy the surface of the solid particles by adsorption and thereby change the surface properties of the solids. The following are examples of these polymers:
  • Phosphonobutanetricarboxylic Acid Polyacrylamidomethylpropanes, Sulfonic Acid, Polycaprolactones, Polyethylacrylates, Polyhydroxystearic Acid,
  • the preparations used contain a plurality of, in particular two different polymers of the same charge and / or in each case an ionic and an amphoteric and / or nonionic polymer.
  • the polymer (G) according to the invention may be both a consolidating and / or film-forming polymer and a polymer having conditioning or avivating and / or thickening properties.
  • the polymers (G) are contained in the compositions used according to the invention preferably in amounts of 0.01 to 30 wt .-%, based on the total composition. Amounts of from 0.01 to 25, in particular from 0.01 to 15 wt .-%, are particularly preferred.
  • compositions according to the invention contain fatty substances (D) as further active ingredient.
  • D fatty substances
  • this composition increased amounts of the active ingredients are deposited on the hair or skin, resulting in synergistically enhanced effects.
  • this effect is further markedly increased by the further use of cationic and / or amphoteric polymers as deposition aids in the compositions according to the invention.
  • There is a Change in the charge of the surface which can be measured for example by measuring the so-called Wilhelmy voltage.
  • Fatty substances (D) are to be understood as meaning fatty acids, fatty alcohols, natural and synthetic waxes, which can be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.
  • fatty acids (D1) it is possible to use linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ® 871 and Emersol ® 875, and isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic as well as their technical mixtures, which are obtained, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxosynthesis or the dimerization of unsaturated fatty acids.
  • Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.
  • the amount used is 0.1 - 15 wt.%, Based on the total mean.
  • the amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.
  • Fatty alcohols (D2) may be used are saturated, mono- or polyunsaturated, branched or unbranched fatty alcohols with C 6 - C o-3, preferably C10 - C22 and most preferably C 12 - C 22 - carbon atoms.
  • the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction.
  • those fatty alcohol cuts which are produced by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, cottonseed oil, soybean oil, sunflower oil and linseed oil or fatty acid esters formed from their transesterification products with corresponding alcohols, and thus represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C14 ®, Lorol C18 ®, ® Lorol C8-18, HD Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or acquire Isocarb® ® 24 for sale.
  • Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®
  • Lorol ® C8 Lorol C8-18
  • wool wax alcohols as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used according to the invention.
  • the fatty alcohols are used in amounts of from 0.1 to 30% by weight, based on the total preparation, preferably in amounts of from 0.1 to 20% by weight.
  • waxes As natural or synthetic waxes (D3) it is possible according to the invention to use solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as, for example, apple wax or citrus wax, microwaxes of PE or PP.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the amount used is 0.1-50 wt.% Based on the total agent, preferably 0.1 to 20 wt.% And particularly preferably 0.1 to 15 wt.% Based on the total agent.
  • the natural and synthetic cosmetic oil bodies (D4) include, for example: vegetable oils.
  • vegetable oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil.
  • triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
  • the compounds are available as commercial products 1, 3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ® S), and di-n-octyl ether (Cetiol ® OE) may be preferred.
  • Ester oils are understood as meaning the esters of Ce - C30 fatty acids with C 2 - C 30 fatty alcohols.
  • the monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • fatty acid components used in the esters are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and Erucic acid and its technical mixtures, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from the Roelen oxo synthesis or the dimerization of uns
  • fatty alcohol moieties in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, Behenyl alcohol, erucyl alcohol and brassidyl alcohol and their technical mixtures, for example, in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from the Roelen oxo synthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols incurred.
  • isopropyl myristate IPM Rilanit ®
  • isononanoic acid C16-18- alkyl ester Cetiol ® SN
  • 2-ethylhexyl palmitate Cegesoft ® 24
  • stearic acid-2- ethylhexyl ester Cetiol ® 868
  • cetyl oleate glycerol tricaprylate, caprate Kokosfettalkohol- / caprylate (Cetiol ® LC)
  • n-butyl stearate oleyl erucate
  • isopropyl palmitate IPP Rilanit ®
  • oleyl Oleate Cetiol ®
  • hexyl laurate Cetiol ® A
  • di-n-butyl adipate Cetiol ® B
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
  • diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2 ethylhexanoate), propylene glycol di-isostearate, propylene glycol di-pelargonat, butanediol di-isostearate, Neopentylgly- koldicaprylat, symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, for example described in DE-OS 197 56 454, glycerol carbonate or dicaprylyl carbonate (Cetiol ® CC),
  • Fatty acid partial glycerides ie monoglycerides, diglycerides and their technical mixtures. With the use of technical products production reasons may still contain small amounts of triglycerides.
  • the partial glycerides preferably follow the formula (D4-I), CH 2 O (CH 2 CH 2 O) m R 1
  • R 1 , R 2 and R 3 are each independently hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, carbon atoms, with the proviso that at least one of these groups represents a Acyl radical and at least one of these groups is hydrogen.
  • the sum (m + n + q) stands for 0 or numbers of 1 to 100, preferably 0 or 5 to 25.
  • R 1 is an acyl radical and R 2 and R 3 are hydrogen and the sum (m + n + q) is 0.
  • Typical examples are mono- and / or diglycerides Base of caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid, and technical mixtures thereof.
  • oleic acid monoglycerides are used.
  • Natural oils include, for example, amaranth seed oil, apricot kernel oil, argan oil, avocado oil, babassu oil, cottonseed oil, borage seed oil, camelina oil, thistle oil, peanut oil, pomegranate seed oil, grapefruit seed oil, hemp oil, hazelnut oil, elderflower seed oil, currant seed oil, jojoba oil, cocoa butter, linseed oil, macadamia nut oil, corn oil, almond oil, marula oil , Evening primrose oil, olive oil, palm oil, rapeseed oil, rice oil, sea buckthorn fruit oil, sea buckthorn seed oil, sesame oil, shea butter, soybean oil, sunflower oil, grapeseed oil, walnut oil or wild rose oil.
  • the following table shows the average wages in% by weight of fatty acids of some of the oils according to the invention. Since the listed values are average values of the respective fatty acids, the sum of all fatty acids can also be greater or less than 100%. Of course, the effective values fluctuate more or less around these averages.
  • Preferred natural oils contain at least all fat-printed fatty acids, palmitic acid, stearic acid and linoleic acid. Particularly preferred natural oils contain the fatty acids palmitic acid, stearic acid and linoleic acid in a total amount of at least 50% by weight of the fatty acids. A plus sign behind the respective oils in the above table characterizes these particularly preferred natural oils. Very particularly preferred oils are further distinguished by a additional content of squalene out. Highly preferred natural oils and their mixtures also have a content of linolenic acids.
  • the teaching of the invention also includes that at least two of the natural oils listed in the above table can be mixed together.
  • the natural oils must be selected so that the sum of the fatty acids palmitic acid, stearic acid and linoleic acid gives at least 50% by weight of the sum of the total fatty acids.
  • Preferred blends of the natural oils are amaranth seed oil with at least one sea buckthorn oil, shea butter amaranth seed oil, camellina oil amaranth seed oil, amaranth seed oil with olive oil, amaranth seed oil with macadamia nut oil, olive oil with at least one sea buckthorn oil, camelina olive oil, shea butter olive oil, macadamia nut oil and at least one sea buckthorn oil, macadamia nut oil shea butter.
  • more than three of the natural oils should not be mixed together.
  • Argan oil is one of the most preferred natural oils and should therefore be described in more detail as an example. Argan oil itself has been known for a long time and is already widely used by humans. It is considered to be the most valuable vegetable oil, which is why it is also called "The Berber Gold.” This is also the reason why it has not found wide use and therefore little is known about the interaction with other ingredients of cosmetic compositions.
  • Argan oil is the oil of the seed of argan fruit.
  • the argan tree, Argania spinosa is one of the oldest trees in the world. Fear with a plum or olive-like appearance can not be consumed. The tree can bear fruit several times a year. The wood, the leaves and the fruits are very valuable and are used. The date-sized fruits are dried and pressed. The kernels of the fruit are won. The kernels are about three times the size of hazelnuts. The kernels are pitched to recover the seeds. These seeds are finally lightly roasted and ground to recover the oil.
  • Argan oil is slightly reddish and has a walnut-like taste. Argan oil is considered the most valuable vegetable oil.
  • argan oil has a uniquely high concentration of unsaturated fatty acids of more than 80 wt.%.
  • Argan oil is an excellent edible oil and dietary supplement. And also in cosmetic compositions argan oil is used because of its high content of vitamin E and unsaturated fatty acids. The importance of argan oil is also based on the unique sterols contained in argan oil, in particular Schottenol and spinasterol.
  • Argan oil contains to tocopherol per 100 g of oil about 50 to 90 mg of tocopherols, which are composed as follows: about 40 to 60 mg tocopherol, about 5 to 15 mg ß-tocopherol, about 5 to 10 mg ⁇ -tocopherol and about 0.5 to 5 mg of ⁇ -tocopherol.
  • the ratio of unsaturated to saturated fatty acids in argan oil is about 4.5: 1.
  • the amount of sterols in the argan oil is about 120 to 250 mg / 100 g of oil.
  • the content of fatty acids is more than 99% by weight, of which more than 80% by weight are unsaturated.
  • the fatty acid composition is approximately as follows: palmitic acid 12 to 13%, stearic acid 5 to 7% and arachidonic acid 0.3 to 0.5% and the unsaturated fatty acids oleic acid 43 to 49.1%, linoleic acid 23.9 to 36.0%, Linoleic acid to 0.1% and gadoleic acid to 0.5%.
  • the amount of linoleic acid in argan oil is about three times higher than that of olive oil.
  • Argan oil is traditionally used for cooking and in cosmetic compositions.
  • the North Africans use argan oil to rub their skin before visiting a steam bath. It penetrates quickly into the skin and leaves a pleasant and soft skin feeling.
  • Argan oil prevents the skin from drying out and aging and is also used to prevent itching. In hair care, it is recommended for brittle and dry hair and hair loss.
  • Amaranth seed oil can be easily incorporated into hair cleansing and conditioner. Incorporated into these compositions, the hair treated therewith remains more glossy and has improved care properties, in particular improved combing properties, more gloss and improved feel.
  • a hair cleanser based on amaranth seed oil requires the least amount of solubilizer, while comparable other oils require a significantly higher amount of solubilizer in order to achieve stable incorporation of the oil in the shampoo.
  • the amaranth seed oil can be stable and clear incorporated into a shampoo at a certain concentration of solubilizers, while many other natural oils have a phase separation.
  • the lipid fraction of the amaranth seeds consists essentially of triglycerides.
  • linoleic acid is the main component in the fatty acid distribution of the oil.
  • Myristic acid, stearic acid, vaccenic acid, ⁇ -linolenic acid, arachidic acid, 11-eicosenoic acid and behenic acid are also present in the fatty acid spectrum.
  • the Amaranthsamenöl rich in many vitamin E derivatives (including ⁇ -, ß-, ⁇ - and ⁇ -tocopherol and ⁇ - and ß-tocotrienol) and has a remarkable proportion of the phytosterols ⁇ 7-avenasterol, ⁇ 7-campesterol, ⁇ 7-sitosterol and ⁇ 7-stigmasterol.
  • a suitable oil according to the invention is available, for example, under the trade name "Amaranth Seed OiI" from the company Euro Ingredients.
  • Shea butter is to be described in more detail as another example of natural oils.
  • Shea butter according to the invention is by no means used alone but only in admixture with at least one further natural oil, so that the total content of the fatty acids palmitic acid, stearic acid and linoleic acid is at least 50% by weight.
  • Shea butter is similar to cocoa butter. Shea butter is obtained from the seeds of the butter tree found in West Africa, Vitellaria paradoxa or Butyrospermum parkii, Sapotacaeae. It is tough-buttery consistency and relatively stable to oxidation. Shea butter is used directly for food purposes in the producer countries. Shea butter is characterized by the following characteristics: saponification number 178 to 196, iodine value 55 to 67, unsaponifiable from 2 to 1 1%. Shea butter has a melting range of 32 to 42 0 C. A characteristic ingredient is the sheasterin, 2-Oleo-distearin.
  • the essential fatty acid composition is oleic acid 49 to 50%, stearic acid 35 to 42%, Palmitic acid 5 to 6% and linoleic acid 4 to 5%. Due to the high proportion of unsaponifiable shea butter has a special status within the vegetable oils and fats. The proportion of unsaponifiable substances is usually only about 0.2 to 2% for vegetable fats. Therefore, the proportion of phytosterols in the shea butter is significantly higher than any other vegetable fats. Important representatives of the phytosterols of shea butter are, for example, ⁇ - and ⁇ -amyrin, Basseol, Parkeol and Lupeol. The structures of ⁇ - and ⁇ -amyrin are as follows:
  • shea butter phytosterols are all triterpenes with more than 15 carbon atoms. Finally, in the shea butter also a share of waxes available.
  • Shea butter is used in cosmetic compositions especially in skin care products. However, it is also included in some compositions for cleaning and care of keratinic fibers.
  • the compositions further contain squalene. Squalene is found in large quantities in shark fishes. In smaller quantities it is also found in some vegetable fats and oils. Squalene is also found in the natural lipid coat of keratinous fibers. Oils of the invention, which also contain squalene and are thus used most preferably according to the invention, can be found in Table 1 on the pages above. Squalene belongs to the triterpenes. The structure of squalene is shown in the following figure.
  • squalene is used in proportion to the combination of the fatty acids in an amount of 1: 1000.
  • a ratio of 1: 100 is preferred.
  • Particularly preferred is a squalene: fatty acid ratio of 1:50, most preferably 1:20 and most preferably 1:10 and most preferably a ratio of 1: 5.
  • the amount used of the natural and synthetic cosmetic oil bodies in the compositions used according to the invention is usually 0.1 to 30% by weight, based on the total composition, preferably 0.1 to 20% by weight, and in particular 0.1 to 15% by weight. -%.
  • One last group of substances that can be used as fatty substances are silicone oils.
  • Silicone oils (S) cause a wide variety of effects. For example, at the same time they influence the dry and wet combability, the grip of dry and wet hair and the shine. But also the softness and the elasticity of the film, which is formed by film-forming polymers on the hair for the purpose of strengthening and styling, is positively influenced by silicones.
  • silicone oils is understood by the person skilled in the art to mean several structures of organosilicon Links. Initially, these are understood to mean the dimethiconols (S1). Dimethiconols form the first group of silicones which are particularly preferred according to the invention.
  • the dimethiconols according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethiconols can be represented by the following structural formula (S1-I): (SiOHR 1 2 ) -O- (SiR 2 2 -O-) x - (SiOHR 1 2 ) (S1-I)
  • Branched dimethiconols can be represented by the structural formula (S1-II):
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, - CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each run independently from 0 up to 50,000.
  • the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
  • Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • the teaching of the invention also includes that the dimethiconols may already be present as an emulsion.
  • the corresponding emulsion of the dimethiconols can be prepared both after the preparation of the corresponding dimethiconols from these and the usual methods of emulsification known to the person skilled in the art.
  • both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions.
  • the emulsions of the dimethiconols can also be prepared directly by an emulsion polymerization process. Such methods are also well known to the person skilled in the art.
  • the droplet size of the emulsified particles is according to the invention from 0.01 ⁇ m to 10000 ⁇ m, preferably from 0.01 to 100 ⁇ m, very particularly preferably from 0.01 to 20 ⁇ m and most preferably from 0.01 to 10 microns.
  • the particle size is determined by the method of light scattering.
  • branched dimethiconols are used, it is to be understood that the branching is greater than a random branching, which occurs by impurities of the respective monomers randomly.
  • branched dimethiconols are therefore to be understood as meaning that the degree of branching is greater than 0.01%.
  • a degree of branching is greater than 0.1%, and most preferably greater than 0.5%.
  • the degree of branching is determined from the ratio of unbranched monomers, that is, the amount of monofunctional siloxane, to the branching monomers, that is, the amount of tri- and tetrafunctional siloxanes. According to the invention both low branched as well as highly branched Dimethiconole be very particularly preferred.
  • Examples of such products include the following commercial products: Botanisil NU-150M (Botanigenics), Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Corning 2-9026 Fluid, Ultrapure Dimethiconol (Ultra Chemical), Unisil SF- R (Universal Preserve), X-21-5619 (Shin-Etsu Chemical Co.), AbN OSW 5 (Degussa Care Specialties), ACC DL-9430 Emulsion (Taylor Chemical Company), AEC Dimethiconol & Sodium Dodecylbenzenesulfonate (A & E Connock (Perfumery & Cosmetics) Ltd.), BC Dimethiconol Emulsion 95 (Basildon Chemical Company, Ltd.), Cosmetic Fluid 1401, Cosmetic Fluid 1403, Cosmetic Fluid 1501, Cosmetic Fluid 1401 DC (all aforementioned Chemsil Silicones, Inc.), Dow Corning 1401 Fluid, Dow Corning 1403 Fluid, Dow Corning 1501 Fluid, Dow Corning 1784 HVF
  • the dimethiconols (S1) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight of dimethiconol based on the composition.
  • the dimethiconols form a separate phase in the compositions according to the invention.
  • the amount of dimethiconol may be up to 40% by weight, preferably in amounts of up to 25% by weight, based on the total composition.
  • Dimethicones (S2) form the second group of silicones, which are particularly preferred according to the invention.
  • the dimethicones according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethicones can be represented by the following structural formula (S2-I): (SiR 1 3 ) -O- (SiR 2 2 -O-) x - (SiR 1 3 ) (S2-I)
  • Branched dimethicones can be represented by the structural formula (S2 - II):
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, - CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, -C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
  • Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • the teaching of the invention also includes that the dimethicones may already be present as an emulsion.
  • the corresponding emulsion of the dimethicones can be prepared both after the preparation of the corresponding dimethicones from these and the usual methods of emulsification known to the person skilled in the art.
  • both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions.
  • the emulsions of dimethicones can also be prepared directly by an emulsion polymerization process. Such methods are also well known to the person skilled in the art. For example, reference may be made to the Encyclopedia of Polymer Science and Engineering, Volume 15, Second Edition, pages 204 to 308, John Wiley & Sons, Inc. 1989. This reference is expressly incorporated herein by reference.
  • the droplet size of the emulsified particles according to the invention is 0.01 ⁇ m to 10000 ⁇ m, preferably 0.01 to 100 ⁇ m, very particularly preferably 0.01 to 20 ⁇ m and most preferably 0.01 to 10 microns.
  • the particle size is determined by the method of light scattering.
  • branched dimethicones are understood to mean that the degree of branching is greater than 0.01%.
  • a degree of branching is greater than 0.1%, and most preferably greater than 0.5%.
  • the degree of branching is determined from the ratio of unbranched monomers, that is, the amount of monofunctional siloxane, to the branching monomers, that is, the amount of tri- and tetrafunctional siloxanes. According to the invention, both low-branched and highly branched dimethicones can be very particularly preferred.
  • the dimethicones (S2) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight of dimethiconone based on the composition.
  • the dimethicones form a separate phase in the compositions according to the invention.
  • it may be appropriate to homogenize the composition shortly before use by shaking it in the short term.
  • the amount of dimethicone may be up to 40% by weight, preferably in amounts of up to 25% by weight, based on the total composition.
  • Dimethicone copolyols (S3) form another group of preferred silicones.
  • Dimethicone copolyols can be represented by the following structural formulas:
  • Branched dimethicone copolyols can be represented by the structural formula (S3-III): R 2
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, - CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • PE stands for a polyoxyalkylene radical.
  • Preferred polyoxyalkylene radicals are derived from Ethylene oxide, propylene oxide and glycerol.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
  • Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • the teaching of the invention also includes that the Dimethiconcopolymere can already be present as an emulsion.
  • the corresponding emulsion of the dimethicone copolyols can be prepared both after the preparation of the corresponding dimethicone copolyols from these and the usual methods of emulsification known to the person skilled in the art.
  • both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions.
  • the emulsions of dimethicone copolyols can also be prepared directly by an emulsion polymerization process.
  • the droplet size of the emulsified particles according to the invention is 0.01 ⁇ m to 10000 ⁇ m, preferably 0.01 to 100 ⁇ m, very particularly preferably 0.01 to 20 ⁇ m and most preferably 0.01 to 10 microns.
  • the particle size is determined by the method of light scattering.
  • branched dimethicone copolyols are used, it is to be understood that the branching is greater than a random branching, which occurs by impurities of the respective monomers randomly.
  • branched dimethicone copolyols are therefore to be understood as meaning that the Branching degree is greater than 0.01%.
  • a degree of branching is greater than 0.1%, and most preferably greater than 0.5%.
  • the degree of branching is determined from the ratio of unbranched monomers, that is, the amount of monofunctional siloxane, to the branching monomers, that is, the amount of tri- and tetrafunctional siloxanes. According to the invention, both low-branched and highly branched dimethicone copolyols can be very particularly preferred.
  • the dimethicone copolyols (S3) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight of dimethicone copolyol based on the composition.
  • the dimethicone copolyols it is also possible for the dimethicone copolyols to form a separate phase in the compositions according to the invention.
  • the amount of Dimethiconcopolyol up to 40 wt.%, Preferably in amounts of up to 25 wt.% Based on the total composition.
  • Aminofunctional silicones or also called amodimethicones (S4), are silicones which have at least one (optionally substituted) amino group.
  • Such silicones may e.g. by the formula (S4-I)
  • R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6 carbon atoms
  • Q is a polar radical of the general formula -R 1 HZ wherein R 1 is a divalent linking group attached to hydrogen and Z is an organic, amino-functional group containing at least one amino-functional group; "a” assumes values in the range of about 0 to about 2, “b” assumes values in the range of about 1 to about 3, “a” + “b” is less than or equal to 3, and “c” is a number ranging from about 1 to about 3, and x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and y is a number in the range of from about 20 to about 10,000, preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art is, preferably trimethylsiloxy.
  • Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur containing radicals such as mercaptoethyl, mercaptopropyl,
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 -, - OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, -C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • Z is an organic, amino-functional radical containing at least one functional amino group.
  • a possible formula for Z is NH (CH 2 ) Z NH 2 , wherein z is 1 or more.
  • Another possible formula for Z is -NH (CH 2 ) Z (CH 2 ) ZZ NH, wherein both z and zz are independently 1 or more, which structure includes diamino ring structures, such as piperazinyl.
  • Z is most preferably a -NHCH 2 CH 2 NH 2 radical.
  • Z is - N (CH 2 ) Z (CH 2 ) ZZ NX 2 or -NX 2 , wherein each X of X 2 is independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.
  • Q is most preferably a polar, amine functional group of the formula - CH 2 CH 2 CH 2 NH 2 CH 2 CH 2 NH 2 .
  • "a” assumes values in the range of about 0 to about 2
  • "b” assumes values in the range of about 2 to about 3
  • "a” + “b” is less than or equal to 3
  • the molar Ratio of R a Q b SiO (4-a - b) / 2 units to R c Si0 (4-c) / 2 units is in the range of about 1: 2 to 1: 65, preferably from about 1: From 5 to about 1:65 and most preferably from about 1:15 to about 1:20.
  • the various variable substituents in the above formula may be present on the various silicone components present in the silicone blend are, be different.
  • Preferred agents according to the invention are characterized in that they contain an amino-functional silicone of the formula (S4-II)
  • G is -H, a phenyl group, -OH, -O-CH 3 , -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 H 3, -CH 2 CH (CH 3) 2, -CH (CH 3) CH 2 CH 3, -C (CH 3) 3;
  • a is a number between 0 and 3, in particular 0;
  • b is a number between 0 and 1, in particular 1,
  • m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably assumes values from 1 to 2000, in particular from 1 to 10,
  • R ' is a monovalent radical selected from O -N (R ") - CH 2 -CH 2 -N (R") 2 o -N (FT) 2 o -N + (R ") 3 A- o -N + H (R ") 2 A " o -N + H 2 (R ") A " o -N (R ”) - CH 2 -CH 2 -N + R” H 2 A " , where each R" is the same or various radicals from the group - H, -phenyl, -benzyl, the Ci -20- alkyl radicals, preferably -CH 3 , - CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 H 3 , -CH 2 CH (CH 3 ) 2 , - CH (CH 3 ) CH 2 CH 3 , -C (CH 3 ) 3! and A represents an anion, which is preferably selected from chlor
  • Particularly preferred agents according to the invention are characterized in that they contain an amino-functional silicone of the formula (S4-III)
  • n and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
  • silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration.
  • compositions according to the invention which are characterized in that they contain an amino-functional silicone of the formula (S4-IV) are also particularly preferred.
  • n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
  • amino-functional silicones are referred to as amodimethicones according to the INCI declaration.
  • agents according to the invention are preferred in which the amino-functional silicone has an amine number above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g ,
  • the amine number stands for the MiIIi- equivalents of amine per gram of amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
  • the amodimethicones (S4) are present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight and in particular from 0.1 to 5% by weight of amodimethicone based on the composition.
  • the amodimethicones it is also possible for the amodimethicones to form a separate phase in the compositions according to the invention.
  • the amount of amodimethicone may be up to 40% by weight, preferably in amounts of up to 25% by weight, based on the total composition.
  • compositions of the invention may contain at least one polyammonium-polysiloxane compound, which is constructed as described below.
  • the polyammonium-polysiloxane compounds contain:
  • a ' means: -CH 2 C (O) -, -CH 2 CH 2 C (O) -, -CH 2 CH 2 CH 2 C (O) -, -C (O) CH 2 -,
  • E represents a polyalkylene oxide group of the general formulas:
  • C 40 hydrocarbon radical which is represented by -O-, -N-, -NR 1 -, -C (O) -, -C (S) -, -N + (R 3 ) - and -
  • N + (R 1 ) (R 3 ) - may be interrupted and substituted with -OH, wherein R 1 is as defined above, or optionally a bond to a bivalent one
  • R represents R 3 , and wherein R 3 is a monovalent or divalent straight-chain, cyclic or branched C 1 -C 20 -hydrocarbon radical which is interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted by -OH may represent, or -AER 2 , wherein A, E and R are as defined above, wherein the radicals K may be the same or different from each other, and in the case that K represents a trivalent radical, the saturation of the third valence via a bond the abovementioned organic radical which contains at least one ammonium group takes place,
  • the polysiloxane compounds according to the invention are characterized in that they have the above-defined components a1) to a4).
  • the polysiloxane compounds are formed by binding of said structural units or radicals a1) to a3) to each other.
  • Component a4) serves to neutralize the positive charges resulting from component a2).
  • the polysiloxane compounds of the invention may be oligomers or polymeric compounds. Oligomeric compounds also include the case described below wherein the polysiloxane compound has only one repeating unit.
  • Polysiloxane compounds of the invention are naturally formed by alternating linkage of divalent radicals.
  • the terminal atom groups result from the terminal atom groups of the starting materials used. This is known per se to the person skilled in the art.
  • the polymeric polysiloxane compounds according to the invention are linear polyammonium-polysiloxane compounds which are composed of the structural components a1) to a3). So can the linear polymeric polysiloxane compounds according to the invention, in particular their formed from the repeat units linear polymeric backbone, by alternating juxtaposition of polyalkylene oxide structural units a1), organic radicals containing at least one, preferably quaternary ammonium group a2) and polysiloxane structural units a3) are constructed. That is, the optionally present in the structural components beyond free valences (as may occur in trivalent radicals as component a2) or trivalent radicals K) are preferably not used to build polymeric side chains or polymeric branches.
  • the main chain of the linear polymeric polysiloxane compounds according to the invention can be built up from the organic radicals containing at least one ammonium group a2) and the polysiloxane structural units a3), and the polyalkylene oxide structural units a1) bind as side chains to the trivalent organic ammonium group radical.
  • the following structures can result:
  • polysiloxane compounds according to the invention may result which have only one repeating unit. This is known per se to the person skilled in the art. This case leads, for example, to inventive polysiloxane compounds of the structure:
  • the polysiloxane compounds according to the invention preferably consist essentially of the components a1) to a4), the polymeric polysiloxane compounds according to the invention naturally having the terminal groups resulting from the reaction of the monomeric starting materials. However, it is also possible to use monofunctional chain terminators.
  • polyalkylene oxide structural units a) may be divalent radicals of the general formulas:
  • the rest A ' means:
  • ethylene oxide / propylene oxide Groupings they may be ethylene oxide / propylene oxide random copolymer groups or ethylene oxide / propylene oxide block copolymer groups with any arrangement of one or more ethylene oxide or propylene oxide blocks.
  • the polyalkylene oxide structural units a1) may furthermore be a monovalent, ie terminal polyalkylene oxide structural unit of the formula: - AER 2 in which A and E have the abovementioned meaning, and R 2 is H, straight-chain, cyclic or branched C 1 - C 2 0 hydrocarbon radical which may be interrupted by -O-, or -C (O) - and substituted with -OH and acetylenic, olefinic or aromatic.
  • the component a2) from which the polysiloxane compounds according to the invention are composed is at least one divalent or trivalent organic radical which contains at least one ammonium group.
  • the binding of the radical to the other components of the polysiloxane compounds of the invention is preferably carried out via the nitrogen atom of one or more ammonium groups in the organic radical.
  • divalent or trivalent means that the organic ammonium radical to form bonds in particular to the other components of the polysiloxane compounds according to the invention has two or three free valences.
  • the ammonium radical is expediently represented by an NH 4 + group in which at least two hydrogen atoms are substituted by organic groups.
  • quaternary ammonium group is by general definition (see, for example, Römpp Chemie Lexikon) a group in which all four hydrogen atoms of an NH 4 + group are replaced by organic radicals.
  • the component a2) of the polysiloxane compounds according to the invention is at least one polysiloxane structural unit of the general formula:
  • S is a polysiloxane group of the general formula
  • R 1 is preferably C 1 -C 8 -alkyl, C 1 -C 8 -fluoroalkyl and aryl. Furthermore, R1 is preferably d-ds-alkyl, d-Ce-fluoroalkyl and aryl. Furthermore, R 1 is preferably C r C 6 alkyl, Ci - C 6 - fluoroalkyl, preferably dC 4 fluoroalkyl, and phenyl. More preferably, R 1 is methyl, ethyl, trifluoropropyl and phenyl.
  • C r C 22 -alkyl in the context of the present invention means that the aliphatic hydrocarbon groups have 1 to 22 carbon atoms, which may be straight-chain or branched. Examples which may be mentioned are methyl, ethyl, propyl, n-butyl, pentyl, hexyl, heptyl, nonyl, decyl, undecyl, isopropyl, neopentyl and 1,2,3 trimethylhexyl.
  • C 1 -C 22 -fluoroalkyl in the context of the present invention means aliphatic hydrocarbon compounds having 1 to 22 carbon atoms which may be straight-chain or branched and are substituted by at least one fluorine atom, by way of example monofluoromethyl, monofluoroethyl, 1,1,1-trifluoroethyl , Perfluorethyl, 1,1,1-trifluoropropyl, 1,2,2-trifluorobutyl.
  • aryl in the context of the present invention are unsubstituted or mono or polysubstituted with OH, F, Cl, CF 3 C r C 6 alkyl, C r C 6 alkoxy, C 3 -C 7 - cycloalkyl, C 2 -C 6 alkenyl or phenyl substituted phenyl.
  • the term may optionally also mean naphthyl.
  • K represents a divalent or trivalent straight-chain, cyclic or branched C 2 -C 4 -OH hydrocarbon radical which is represented by -O-, -NH-, -N-, C (O) -, -C (S) -, - N + (R 3 ) -, -NR 1 -, and -N + (R 1 ) (R 3 ) - may be interrupted and substituted with -OH.
  • the group K binds via a carbon atom to the silicon atom of the group S.
  • the group K can, as seen above, also preferably have quaternary ammonium groups, so that ammonium groups result in addition to the ammonium groups in said component a2) in the polysiloxane compounds according to the invention.
  • the polysiloxane compounds according to the invention can, for example in the radical K, have amino groups.
  • the reaction of the polysiloxane compounds according to the invention with acids leads to their protonation.
  • Such protonated amino group-containing polysiloxane compounds are included in the scope of the present invention.
  • the bonding of component a3), the polysiloxane structural unit -K-S-K-, to the other structural components via the radical K preferably does not take place via a nitrogen atom of the radical K.
  • R 1 is as defined above or optionally represents a bond to a divalent radical R 3 , so that a cycle results.
  • R 3 represents a monovalent or divalent straight-chain, cyclic or branched C 1 -C 20 -hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted by -OH , or -AER 2 , wherein A, E and R 2 are as defined above.
  • the radicals K can be identical or different from one another, and in the case where K represents a trivalent radical, the saturation of the third valence takes place via a bond to the abovementioned organic radical which contains at least one ammonium group.
  • the polysiloxane compounds according to the invention furthermore contain component a4), at least one organic or inorganic anionic acid radical for neutralizing the charges resulting from the (n) ammonium group (s).
  • Organic or inorganic acid radicals are radicals that formally result from the elimination of one or more protons from organic or inorganic acids and include, for example, halides such as fluoride, chloride, bromide, sulfates, nitrates, phosphates, carboxylates such as formate, acetate, propionate etc., sulfonates, sulfates, polyether carboxylates and polyether sulfates etc. Chloride is preferred.
  • the organic or inorganic anionic acid radicals as component a4) of the polysiloxane compounds according to the invention may be identical or different from one another.
  • halide ions preferably result from the reaction of the amines with alkyl halides, while, for example, carboxylates result from the carboxylic acids which can be added in the reaction of bisepoxides with amines.
  • K represents a divalent or trivalent straight-chain, cyclic or branched C 2 -C 40 -hydrocarbon radical which is represented by -O-, -NH-, -N-, -NR 1 -, -C (O) -, -C (S) - may be interrupted and substituted with -OH, wherein R 1 is as defined above, and wherein the radicals K may be the same or different from each other.
  • organic radical which contains at least one, preferably quaternary ammonium, group is preferably a radical of the general formula:
  • N 1 is a quaternary ammonium group of the general formula - (R 4 ) N + (R 5 ) -, in which
  • R 4 is a monovalent or divalent straight-chain, cyclic or branched d C 2 o hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted by -OH
  • R 5 is a monovalent straight-chain, cyclic or branched dC 2 o-hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted by -OH, or a single bond to a divalent radical R 4 or a tetravalent radical F
  • the radicals R 4 and R 5 within the group -N 1 -FN 1 - as well as in the polysiloxane compound may be the same or different from each other
  • F is a divalent or tetravalent straight-chain, cyclic or branched C 2 -C 30 -hydrocarbon radical which is represented by -O-, -NH-, -N-, - C (O) -, -C (S) -, a siloxane chain S, where S is the above-mentioned references, interrupted and can be substituted with -OH.
  • organic radical which contains at least one, preferably quaternary ammonium, group may furthermore preferably be a radical of the general formula - (R 6 ) N + (R 7 ) -, in which R 6 is a monovalent or divalent straight-chain, cyclic or branched d C 30 hydrocarbyl radical which is represented by -O-, -NH-,
  • -C (O) -, -C (S) - may be interrupted and substituted with -OH, or R 6 represents a single bond to a trivalent radical K.
  • R 7 is a monovalent straight-chain, cyclic or branched CrC 20 hydrocarbon radical which may be interrupted by -O-, -NH- -C (O) -, -C (S) - and substituted by -OH, or -AER 2 , wherein -AER 2 has the abovementioned meaning, or a single bond to a divalent radical R 6 or to a trivalent radical K.
  • the radicals R 6 and R 7 may be the same or different from each other.
  • the aforementioned organic radical containing at least one ammonium group may furthermore preferably be a radical of the general formula: -N 5 -F 1 -N 5 -, where N 5 is an ammonium group of the general formula - (R 23 ) N + (R 24 ) - is, in which
  • R 23 is hydrogen, a monovalent or divalent straight-chain, cyclic or branched C by -O-, -NH-, -C (O) -, -ununterbrochen and may be substituted with -OH,
  • R 24 represents hydrogen, a monovalent straight-chain, cyclic or branched C 1 -C 20 hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O) -, -C (S) and substituted by -OH, or represents a single bond to a divalent radical R 23 , and the radicals R 23 and R 24 within the group -N 5 -F 1 -N 5 - as well as in the polysiloxane compound may be identical or different from each other, F 1 represents a bivalent straight-chain, is a cyclic or branched -N hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O) -, -N-, -C (S) - or by a group -E-,
  • a particular embodiment of the polyammonium-polysiloxane compounds (which will be referred to as the first embodiment of component a) of the active ingredient complex), wherein the aforementioned organic radical containing at least one, preferably quaternary ammonium, as component a2) of the polysiloxane compounds according to the invention a radical the general formula:
  • B is -AEKSKEA- and additionally -AE-A'- or -AEA-, where S, K, -AE-, - EA-, -AE-A 'or -A'-EA- and - N 1 -FN 1 - are as defined above, and the proportion of the group -AE-A 'or -A'-EA- in the group B may be chosen so that the mass of -AE-A'- or -A'-EA- from 0 to 90%, preferably 0% or 0.1 to
  • the first embodiment of the polyammonium-polysiloxane compounds preferably relates to linear alkylene-oxide-modified polyquaternary polysiloxanes of the general formula (I 1 )
  • K is a divalent straight-chain, cyclic or branched C 2 -C 2O -
  • Hydrocarbon radical which may be interrupted by -O-, -NH-, -NR 1 -, -C (O) -, -C (S) and substituted by -OH
  • E is a polyalkylene oxide unit of the structure - [CH 2 CH 2 O] Cl - [CH 2 CH (CH 3 ) O] r - with, q 1 to 200, r 0 to 200 and
  • A is -CH 2 C (O) O-, -CH 2 CH 2 C (O) O- or -CH 2 CH 2 CH 2 C (O) O-,
  • N 1 is a quaternary ammonium structure - (R 4 ) N + (R 5 ) -
  • R 4 represents a monovalent or divalent straight-chain, cyclic or branched C 1 -C 20 -hydrocarbon radical which is interrupted by O-, -NH, -C (O) -, -C (S) - and may be substituted with -OH
  • R 5 represents R 4 or a single bond to R 4 or F
  • F is a divalent or tetravalent straight-chain, cyclic or branched C 2 -C 30 hydrocarbon radical which is represented by -O-, -NH-, -N-, -C (O) -, -C (S) -, a siloxane chain S , wherein for S the above-mentioned references apply, can be interrupted and substituted with -OH.
  • F can form a branched or ring system with the limiting N 1 , so that F then participates with two bonds at each quaternization of both limiting N 1 .
  • F can form a branched or ring system with the limiting N 1 , so that F then participates with two bonds at each quaternization of both limiting N 1 .
  • the possibility of a divalent substructure for R 4 means that in these cases it is a cyclic-structure-forming structure in which R 5 in this case is a single bond to R 4 .
  • Examples are morpholinyl and piperidinyl structures. More preferred embodiments of this so-called first embodiment of the invention and processes for the preparation of said polysiloxane compounds of the formula (I) or (I 1 ) are described below.
  • R 4 is preferably -CH 3 , -CH 2 CH 3 , - (CH 2 ) 2 CH 3 , - (CH 2 ) 3 CH 3 , - (CH 2 ) 5 CH 3 , -CH 2 CH 2 OH, - CH 2 CH 2 NHCO-R 14 or -CH 2 CH 2 CH 2 NHCO-R 14 , wherein wherein R 14 is a straight-chain, cyclic or branched CrCi 8 - hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted with -OH.
  • R 4 and R 5 can also together form a cyclic structure of the formulas
  • R 1 in the so-called first embodiment of the polysiloxane compounds can be referred to the above statements.
  • R 4 is preferably a monovalent or divalent straight-chain, cyclic or branched C 1 -C 1 6, more preferably C 3 -C 6 -hydrocarbon radical which is represented by -O-, -NH-, -C ( O) -, -C (S) - and may be substituted by -OH, more preferably a C 3 - C 16 - hydrocarbon radical represented by -O-, -NH-, -NR 1 -, -C (O) - , -C (S) - may be interrupted and substituted with - OH, wherein R 1 has the abovementioned meaning.
  • F is preferably a divalent or tetravalent straight-chain, cyclic or branched C 2 -C 2 O hydrocarbon radical which is represented by -O-, -NH-, -N-, - C (O) -, - C (S), a siloxane chain S, where S is the above-mentioned references, may be interrupted and substituted with -OH.
  • R 14 is preferably unsubstituted C 5 -C 7 -hydrocarbon radicals derived from the corresponding fatty acids or hydroxylated C 3 -C 7 radicals which can be attributed to hydroxylated carboxylic acids, preferably saccharide carboxylic acids.
  • R 14 furthermore preferably represents hydroxylated radicals from the group consisting of
  • m is 2 to 100, preferably 2 to 50.
  • n is 0 to 1000, preferably 0 to 100, more preferably 0 to 80 and particularly preferably 10 to 80.
  • q is 1 to 200, preferably 1 to 50, more preferably 2 to 20 and particularly preferably 2 to 10.
  • r is 0 to 200, preferably 0 to 100, more preferably 0 to 50, and even more preferably 0 to 20.
  • a particular embodiment of the invention (which is referred to below as the so-called second embodiment of the polysiloxane compounds) is represented by the polysiloxane compounds of the general formula (II),
  • N 2 is an organic radical containing at least one quaternary ammonium group, the general formula
  • R 8 is a monovalent or divalent straight-chain, cyclic or branched -C 2 o hydrocarbyl group represented by -0-, -NH-, -C (O) -, - C (S) - may be substituted with -OH and interrupted,
  • R 9 is a monovalent straight-chain, cyclic or branched dC 2 o hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted by -OH, or a single bond to a divalent radical R 8 or to a trivalent radical K, and the radicals R 8 and R 9 within the polysiloxane compound of the general formula (II) may be identical or different from each other.
  • the polysiloxane compounds of the second embodiment are preferably (-alkylene oxide and polyquaternary modified polysiloxanes of the general formula (II 1 )
  • -NR 1 -, -C (O) -, -C (S) - may be interrupted and substituted with -OH, N 2 is a quaternary ammonium structure
  • R 8 is a monovalent or divalent straight-chain, cyclic or branched -C 2 o-hydrocarbon radical, interrupted by -O-, -NH-, C (O) -, -C (S) - and substituted with -OH,
  • R 9 R 8 or a single bond to K or R 8 , A is -CH 2 C (O) O-, -CH 2 CH 2 C (O) O- or -CH 2 CH 2 CH 2 C (O) O-
  • E is a polyalkylene oxide unit of the structure
  • R 16 H straight-chain, cyclic or branched CrC 20 -
  • -OH can be substituted and acetylenic, olefinic or aromatic.
  • K can be branched and then participates with two bonds in the quaternization of N 2 .
  • divalent substructure for R 8 means that in these cases it is a cyclic-structure-forming structure, where R 9 is then a single bond to R 2 .
  • R 8 is preferably -CH 3 , -CH 2 CH 3 , - (CH 2 ) 2 CH 3 , - (CH 2 ) 3 CH 3 , - (CH 2 ) 5 CH 3 , -CH 2 CH 2 OH -CH 2 CH 2 NHCO-R 17 or -CH 2 CH 2 CH 2 NHCO-R 17 , in which R 17 denotes a straight-chain, cyclic or branched C 1 -C 8 -hydrocarbon radical which is represented by -O-, -NH-, -C ( O) -, -C (S) - may be interrupted and substituted with -OH.
  • R 8 and R 9 may also together form a cyclic structure of the formulas
  • CH2-CH2 form CH2-CH2.
  • R 1 in the so-called second embodiment of the polysiloxane compounds can be referred to the above statements.
  • K is preferably a divalent or trivalent straight-chain, cyclic or branched one
  • -C (S) - may be interrupted and substituted with -OH, wherein R 1 is as defined above.
  • Preferred for K are, for example, radicals of the following structures:
  • R 8 is preferably a monovalent or divalent straight-chain, cyclic or branched C 1 -C 6 -hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O), -C (S) - and substituted by -OH ,
  • R 16 is preferably a straight-chain, cyclic or branched C 1 -C 8 -hydrocarbon radical which may be interrupted by -O- or -C (O) - and substituted by -OH and may be acetylenic or olefinic.
  • R 17 preferably represents unsubstituted C 5 -C 7 -hydrocarbon radicals which are derived from the corresponding fatty acids or hydroxylated C 3 -C 7 radicals which are based on hydroxylated carboxylic acids, preferably can be attributed to saccharide carboxylic acids, is.
  • R is more preferably selected from the group
  • n is preferably 0 to 200, more preferably 0 to 80, particularly preferably 10 to 80.
  • q is preferably 1 to 50, more preferably 2 to 20, and particularly preferably 2 to 10.
  • r is preferably 0 to 100, and more preferably 0 to 50.
  • r is preferably 0 to 20, and more preferably 0 to 10.
  • polyammonium-polysiloxane compounds a) as an essential constituent of the active ingredient complex according to the invention (which is referred to below as the so-called third embodiment of the polysiloxanes) is represented by the polysiloxane compounds of the general formula (III): - [KSKN 3 Jm- (III)
  • N 3 is an organic radical containing at least one quaternary ammonium group of the general formula
  • R 10 is a monovalent straight chain, cyclic or branched C 1 -C 30 hydrocarbon radical represented by -O-, -NH-, -C (O) -, -C (S) - may be interrupted and substituted by -OH or represents a single bond to K
  • R 11 is -AER 2 , wherein -AER 2 has the abovementioned meaning.
  • the polysiloxane compounds of the third embodiment are alkylene oxide-modified polyparternary polysiloxanes of the general formula (IN ' ),
  • R 10 is a monovalent or divalent straight-chain, cyclic or branched dC 3 o-hydrocarbon radical which is represented by -O-, -NH-,
  • -C (O) -, -C (S) - may be interrupted and substituted with -OH or a
  • A is -CH 2 C (O) O-, -CH 2 CH 2 C (O) O- or - CH 2 CH 2 CH 2 C (O) O- and E is a polyalkylene oxide unit of structure
  • R 18 is H, straight-chain, cyclic or branched C 1 -C 20 -hydrocarbon radical which may be interrupted by -O- or -C (O) - and substituted by -OH and may be acetylenic, olefinic or aromatic, and
  • K is a divalent or trivalent straight-chain, cyclic or branched C 2 -C 4O-
  • Hydrocarbon radical which may be interrupted by -O-, -NH-, - NR 1 -, -N-, -C (O) -, -C (S) - and substituted by -OH or contains a quaternary ammonium structure N 5 , With
  • R 19 is a monovalent or divalent straight-chain, cyclic or branched C 1 -C 20 -
  • a hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted by -OH or represents a single bond to R 10 , and R 20 is -AE-, the as defined above.
  • R 10 and R 19 are independently of one another preferably -CH 3 , -CH 2 CH 3 , - (CH 2 ) 2 CH 3 , - (CH 2 ) 3 CH 3 , - (CH 2 ) 5 CH 3 , -CH 2 CH 2 OH, -CH 2 CH 2 NHCOR 21 or - CH 2 CH 2 CH 2 NHCOR 21 , wherein R 21 is a straight-chain, cyclic or branched d- Ci ⁇ hydrocarbon radical represented by -O-, -NH-, -C (O ) -, -C (S) - may be interrupted and substituted with -OH.
  • a bivalent substructure for R 10 is a cyclic system-forming structure wherein R 10 then has a single bond to K, preferably to a tertiary amino structure or to the quaternary structure N 5 over R 19 .
  • R 10 is a monovalent or divalent straight chain, cyclic or branched C 1 -C 25 hydrocarbon radical which may be substituted by -O-, -NH-, -C (O) -, -continuous and -OH.
  • R 19 is a monovalent or divalent straight chain, cyclic or branched CrC 25 hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted with -OH.
  • K is furthermore preferably a bivalent or trivalent straight-chain, cyclic or branched C 3 -C 30 -hydrocarbon radical which is represented by -O-, -NH-, -NR 1 -, -N-, -C (O) -, -C (S) - may be interrupted and substituted with -OH, more preferably K is -CH 2 CH 2 CH 2 OCH 2 CHOHCH 2 -,
  • R 20 is as defined above.
  • R 2 or R 18 is preferably a straight-chain, cyclic or branched C 1 -C 8 -hydrocarbon radical which is interrupted by -O- or -C (O) - and -OH substituted and acetylenically or can be olefinic. More preferably R 2 or R 18 is C r C 6 -alkyl,
  • R 21 is an unsubstituted Cs-Ci T hydrocarbon radical derived from the corresponding fatty acids or having hydroxylated C 3 -C 7 residues, and from the group of hydroxylated carboxylic acids, preferably derived from saccharide carboxylic acids.
  • R 21 is:
  • m is preferably 2 to 100, and more preferably 2 to 50
  • n is 0 to 100, preferably 0 to 80, and particularly preferably 10 to 80
  • q is 1 to 50, preferably 2 to 50 particularly preferably 2 to 20, and more preferably q is 2 to 10
  • r is 0 to 100, preferably 0 to 50, more preferably 0 to 20, and even more preferably r is 0 to 10.
  • polysiloxanes which is referred to below as the so-called fourth embodiment of the polysiloxanes to be used according to the invention
  • N 4 is an organic radical containing at least one quaternary ammonium group of the general formula - (R 12 ) N + (R 13 ) - where R 12 is a monovalent or divalent radical is straight-chain, cyclic or branched C 1 -C 20 -hydrocarbon radical which may be interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted by -OH, R 13 are the meanings of R 12 , or represents a single bond to K or R 12 , and R 12 and R 13 may be the same or different from each other.
  • the polysiloxane compounds of the fourth embodiment are preferably alkylene oxide-modified polyquartezere polysiloxanes of the general formula (IV),
  • R 1 is C r C 22 alkyl, C r C 22 fluoroalkyl or aryl, n is O to 1000, K is a bivalent, or trivalent straight-chain, cyclic or branched
  • C 2 -C 2O - represents hydrocarbon radical, interrupted by -O-, -NH-,
  • N is a quaternary ammonium structure - (R 12 ) N + (R 13 ) -, wherein R is 12 is a monovalent or divalent straight-chain, cyclic or branched CrC 20 -
  • R 13 is R 12 or a single bond to K or R 12
  • A is -CH 2 C (O) O-, -CH 2 CH 2 C (O) O- or -CH 2 CH 2 CH 2 C (O) O-
  • the possibility of a trivalent substructure for K means that K can be branched and then be involved with two bonds in the quaternization of N 4 .
  • the possibility of a divalent substructure for R 12 means that in these cases it is a cyclic-structure-forming structure, where R 13 is then a single bond to R 12 .
  • R 12 is preferably -CH 3 , -CH 2 CH 3 , - (CH 2 ) 2 CH 3 , - (CH 2 ) 3 CH 3 , - (CH 2 ) 5 CH 3 , -CH 2 CH 2 OH, -CH 2 CH 2 NHCOR 22 or -CH 2 CH 2 CH 2 NHCOR 22 , in which R 22 is a straight-chain, cyclic or branched C 1 -C 8 -hydrocarbon radical which is represented by -O-, -NH-, -C (O) - , -C (S) - may be interrupted and substituted with -OH.
  • R 12 and R 13 may also together form a cyclic structure of the formulas
  • R 12 is preferably a monovalent or divalent straight-chain, cyclic or branched C 1 -C 6 -hydrocarbon radical which is interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted by -OH can.
  • K is preferably a bivalent or trivalent straight-chain, cyclic or branched C 3 -C 6 -hydrocarbon radical which is represented by -O-, -NH-, -NR 1 -, -N-, -C (O ) -, -C (S) - may be interrupted and substituted with -OH, more preferably K is -CH 2 CH 2 CH 2 -, -CH 2 CH 2 CH 2 OCH 2 CHOHCH 2 - or
  • R 22 is an unsubstituted C 5 -C 17 hydrocarbon radical derived from the corresponding fatty acids or having hydroxylated C 3 -C 17 radicals which may be attributed to hydroxylated carboxylic acids, preferably saccharide carboxylic acids.
  • R22 More preferred is R22.
  • m is preferably 2 to 100, and particularly preferably 2 to 50.
  • n is 0 to 100, preferably 0 to 80, and particularly preferably 10 to 80.
  • q is 1 to 50, preferably 2 to 50, and particularly preferably 2 to 20, more preferably q is 2 to 10.
  • r is 0 to 100, preferably 0 to 50, and more preferably 0 to 20, more preferably r is 0 to 10.
  • C 1 -C 22 -alkyl or C 1 -C 30 -hydrocarbon radical as used above means in the context of the present invention aliphatic hydrocarbon compounds having 1 to 22 carbon atoms or 1 to 30 carbon atoms which may be straight-chain or branched. Examples which may be mentioned are methyl, ethyl, propyl, n-butyl, pentyl, hexyl, heptyl, nonyl, decyl, undecyl, isopropyl, neopentyl, and 1,2,3-trimethylhexyl.
  • C r C 22 fluoroalkyl as used above means in the context of the present invention aliphatic hydrocarbon compounds having 1 to 22 carbon atoms which may be straight-chain or branched and are substituted by at least one fluorine atom. Examples include monofluoromethyl, monofluoroethyl, 1,1,1-trifluoroethyl, perfluoroethyl, 1,1,1-trifluoropropyl, 1,2,2 trifluorobutyl listed.
  • aryl in the context of the present invention means unsubstituted or mono- or polysubstituted by OH, F, Cl, CF 3 C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 3 -C 7 -cycloalkyl, C 2 -C 6 alkenyl or phenyl substituted phenyl.
  • the term may optionally also mean naphthyl.
  • a particular embodiment of the polysiloxanes according to the invention as constituent a) of the active ingredient complex according to the invention (which is referred to below as the so-called fifth embodiment of the polysiloxanes) is represented by the polysiloxanes of the general formula (V):
  • the groups K, S, -AE-A'- and -A'-EA- within the polysiloxanes of the general formula (V) may be the same or different from each other, and the molar ratio of the group -KSK- and the group -AE-A'- or -A'-EA- in the polysiloxane compound of the general formula (V) of 100: 1 to 1: 100,
  • N 5 is an ammonium group of the general formula - (R 23 ) N + (R 24 ) -, in which
  • R 23 represents hydrogen, a monovalent or divalent straight-chain, cyclic or branched dC 2 o-hydrocarbon radical which is interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted by -OH
  • R 24 can be hydrogen, a monovalent straight-chain, cyclic or branched C 1 -C 20 hydrocarbon radical which is interrupted by -O-, -NH-, - C (O) -, C (S) - and substituted by -OH may be, or a single bond to a divalent radical R 23 , and the radicals R 23 and R 24 within the group -N 5 -F 1 -N 5 - as well as in the polysiloxane compound may be the same or different,
  • F 1 is a bivalent straight-chain, cyclic or branched hydrocarbon radical which may be interrupted by -O-, -NH-, -N-, -C (O) -
  • the molar ratio of the group -KSK- and the group -AE-A ' or -A ' -EA- in the polysiloxane compound of the general formula (V) is between 100: 1 and 1: 100.
  • This molar ratio can, as in the publication WO 02/10257, by the choice of the molar ratio of the starting compounds, in particular the ratio of the invention preferably used (, -
  • Halocarboxylic acid polyalkylene oxide ester compounds and the polysiloxane bisepoxide compounds are controlled.
  • the properties of the products depend essentially on the ratio of the starting materials used, as well as the length of the polyalkylene oxide or polysiloxane blocks contained therein.
  • K is a divalent hydrocarbon radical having at least 4 carbon atoms which has a hydroxyl group and which may be interrupted by an oxygen atom.
  • F1 is a divalent straight-chain, cyclic or branched C 2 -C 30 hydrocarbon radical which is represented by -O-, -NH-, -N-, -C (O) -, -C (S) - or may be interrupted by a group - E -, wherein E is as defined above, and wherein the carbon atoms resulting from the radical E are not counted among the 2 to 30 carbon atoms of the C 2 -C 30 hydrocarbon radical ,
  • R 25 is a monovalent or divalent straight-chain, cyclic or branched C 1 -C 20 -hydrocarbon radical which is interrupted by -O-, -NH-, -C (O) -, -C (S) - and substituted by -OH may, particularly preferably is methyl,
  • R 26 a monovalent straight chain, cyclical or branched C 1 -C lenwasserstoffrest 2 0- Koh by -O-, -NH-, -C (O) - may be substituted OH, -, -C (S) is interrupted and with more preferably methyl or a single bond to a divalent radical R 25 , and the radicals R 25 and R 26 within the group -N 5 -F 2 -N 5 - as well as in the polysiloxane compound may be the same or different from each other, and
  • F 2 is a divalent straight-chain, cyclic or branched hydrocarbon radical which may be interrupted by -O-, -NH-, -N-, -C (O) -, -C (S) -.
  • F 2 is a branched, preferably straight-chain, C 1 -C 6 -alkanediyl group, of which a 1,6-hexanediyl (or hexamethylene) group is preferred.
  • R 27 and R 28 are each hydrogen, C r C 6 alkyl or hydroxy (C r C 6 ) alkyl, preferably hydrogen, methyl or -CH 2 CH 2 OH, and
  • F 3 is a divalent straight chain, cyclic or branched hydrocarbon radical interrupted by a group -E-, wherein E is as defined above.
  • F 3 is particularly preferably a group of the formula
  • E is as defined above and D is each a single bond or a straight or branched C 1 -C 6 alkanediyl group, with the proviso that D is not a single bond when it binds to a terminal E group oxygen atom.
  • the group -DED- is replaced by a group of the formula
  • D is a straight or branched C 1 -C 6 alkanediyl group and r and q are as defined above.
  • XOD- may be the ethylene oxide
  • Propylene oxide units may be arranged arbitrarily, e.g. as a random copolymer unit or as a block copolymer unit.
  • v is preferably 1 to 100, more preferably 1 to 70, still more preferably 1 to 40.
  • w is preferably 0 to 100, more preferably 0 to 70, even more preferably 0 to 40.
  • polysiloxane compounds of the general formula (V) are composed of two different types of the group -N 5 -F 1 -N 5 -.
  • the polysiloxane compounds of the general formula (V) may be cyclic or linear.
  • the terminal groups either result from the bifunctional monomers or their functionalized derivatives described below, or from monoamines added as chain terminators during the polymerization.
  • the terminal groups resulting from the use of the monoamine chain-stopper are preferably present as ammonium groups, either by quaternization or protonation.
  • K is one of the groups of the formula:
  • polysiloxanes q is preferably in the range from 1 to 50, in particular 2 to 50, especially 2 to 20 and especially 2 to 10, and r is in the range of 0 to 100, in particular 0 to 50, especially 0 to 20 and especially 0 to 10.
  • the organic or inorganic acid radical for neutralizing the charges resulting from the (n) ammonium group (s) is expediently selected from inorganic radicals such as chloride, bromide, hydrogensulfate, sulfate, or organic radicals such as acetate, Propionate, octanoate, decanoate, dodecanoate, tetradecanoate, hexadecanoate, octadecanoate and Oleat, wherein as mentioned above, chloride and bromide preferably result from the reaction of the alkyl halide groups with amine groups.
  • inorganic radicals such as chloride, bromide, hydrogensulfate, sulfate, or organic radicals such as acetate, Propionate, octanoate, decanoate, dodecanoate, tetradecanoate, hexadecanoate, octadecanoate and Oleat, wherein as mentioned above, chloride and
  • polysiloxanes of the fifth embodiment are present in protonated form as amine salts or as amines.
  • polysiloxanes of the fifth embodiment of the invention are conveniently prepared by one of the methods described in the laid-open specification WO 02/10257.
  • the polyammonium-polysiloxane compounds described above can be obtained for example under the tradename Baysilone ® from GE Bayer Silicones.
  • the products with the names Baysilone TP 391 1, SME 253 and SFE 839 are preferred. Very particular preference is given to the use of Baysilone TP 3911 as the active component of the compositions according to the invention.
  • polyammonium-polysiloxane compounds described above are very particularly preferred in the compositions according to the invention in an amount of from 0.01 to 10% by weight, preferably from 0.01 to 7.5, particularly preferably from 0.01 to 5.0% by weight from 0.05 to 2.5% by weight each based on the total composition.
  • the ratio of the polyammonium-polysiloxane compounds to a further synergistic active ingredient component selected from the group of polymers, the protein hydrolysates, the silicones, the vitamins and the plant extracts is generally 1: 1000 to 1: 2, preferably 1: 100 to 1: 2 , more preferably 1:50 to 1: 2, and most preferably 1:10 to 1: 2.
  • this mixture is present in the compositions according to the invention in amounts of from 0.01 to 10% by weight, preferably from 0.01 to 8% by weight, particularly preferably from 0.1 to 7.5% by weight .% And in particular 0.1 to 5 wt.% Of silicone mixture based on the composition.
  • the mixture of silicones form a separate phase in the compositions according to the invention. In this case, it may be appropriate to homogenize the composition shortly before use by shaking it in the short term.
  • the amount of silicone mixture may be up to 40% by weight, preferably in amounts of up to 25% by weight, based on the total composition.
  • teaching of the invention also includes that a mixture of several fatty substances (D) from different classes of fatty substances, at least two different classes of fatty substances in the inventive
  • compositions can be used.
  • the preferred mixtures of at least two oil and fat components necessarily contain at least one further silicone component in this case.
  • the silicone component in this case is selected from the dimethiconols and the amodimethicones.
  • the total amount of oil and fat components in the compositions according to the invention is usually 0.5-75% by weight, based on the total agent. Amounts of 0.5-35 wt .-% are preferred according to the invention.
  • compositions according to the invention with the active ingredient according to the invention are complex protein hydrolysates and / or its derivatives (P).
  • Proteins and / or protein hydrolysates are able to significantly restructure the internal structure of the skin and hair.
  • Strengthening of the structure that is to say restructuring in the sense of the invention, is to be understood as meaning a reduction in the damage to the skin caused by most diverse influences.
  • the restoration of natural strength plays an essential role.
  • Restructured areas of the skin and restructured hair are characterized, for example, by improved strength, reduced roughness or improved grip.
  • they have an optimized strength and elasticity.
  • Proteins and protein hydrolysates have been known for a long time and are widely used in cosmetics. Reference is made to the relevant literature.
  • compositions according to the invention As a result, in particular an increase in the mildness and the skin compatibility but also, if desired, a fine creamy foam is achieved when using the compositions according to the invention.
  • This foam which is very fine in structure, creamy and extremely pleasant to the touch, is achieved in all compositions in which, in particular, surface-active substances are contained as further ingredients.
  • the effectiveness of the composition according to the invention is further increased by the simultaneous use of polymers and / or penetration and swelling aids. In these cases, even after the application of the particular composition significantly more protein hydrolyzate or its derivative remains on the surface of the hair, resulting in an improved effect. The hair is thus significantly strengthened and smoothed in its structure.
  • Protein hydrolysates are product mixtures obtained by acid, alkaline or enzymatically catalyzed degradation of proteins (proteins).
  • the term protein hydrolyzates also means total hydrolyzates as well as individual amino acids and their derivatives as well as mixtures of different amino acids.
  • polymers under the term protein hydrolysates include, for example, polyalanine, polyasparagine, polyserine, etc.
  • compounds which can be used according to the invention are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride.
  • ⁇ -amino acids and their derivatives such as ⁇ -alanine, anthranilic acid or hippuric acid can also be used.
  • the molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.
  • the present teaching according to the invention also encompasses that in the case of the amino acids, these may be present in the form of derivatives such as, for example, the N-acyl derivatives, the N-alkyl or the O-esters.
  • the acyl group is a formyl radical, an acetyl radical, a propionyl radical, a butyryl radical or the radical of a straight-chain, branched or unbranched, saturated or unsaturated fatty acid having a chain length of 8 to 30 carbon atoms.
  • the alkyl group may be linear, branched, saturated or unsaturated and has a C chain length of 1 to 30 carbon atoms.
  • the alcohols on which the esterification is based are methanol, ethanol, isopropanol, propanol, butanol, isobutanol, pentanol, neopentanol, isopentanol, hexanols, heptanols, caprylic or caproic alcohol, octanols, nonanols, decanols, dodecanols, lauranols, in particular saturated or unsaturated, linear or branched alcohols having a C chain length of 1 to 30 carbon atoms.
  • the amino acids can be simultaneously derivatized both at the N atom and at the O atom.
  • the amino acids can also be used in salt form, in particular as mixed salts together with edible acids. This may be preferred according to the invention.
  • amino acids and their derivatives as protein hydrolysates according to the invention are: alanine, arginine, carnitine, creatine, cystathionine, cysteine, cystine, cystic acid, glycine, histidine, homocysteine, homoserine, isoleucine, lanthionine, leucine, lysine, methionine, norleucine, norvaline , Ornithine, phenylalanine, proline, hydroxyproline, sarcosine, serine, threonine, tryptophan, thyronine, tyrosine, VaNn, aspartic acid, asparagine, glutamic acid and glutamine.
  • Preferred amino acids are alanine, arginine, glycine, histidine, lanthionine, leucine, lysine, proline, hydroxyproline serine and asparagine.
  • Alanine, glycine, histidine, lysine, serine and arginine are very particularly preferably used. Most preferably, glycine, histidine, lysine and serine are used.
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (Inolex) and kerasol tm ® (Croda) sold.
  • Moringa growths have been known since ancient times. Better known are plants of this species under their common name “Wunderbaum.” They are preferably native to tropical areas.The various parts of this genus of plants have been used since ancient times, especially for medical purposes.
  • This protein has a molecular weight of 500 to 50,000 daltons
  • Preferred is a P rotein extra kt having a molecular weight of 3,000 to 30,000 daltons, most preferably from 5,000 to 15,000 daltons Extract is obtained from the plant Moringa Oleifera.
  • the extract according to the invention naturally contains water and glycerol on account of the extraction. The content of extracted protein in the extract is 0.01 to 20% by weight.
  • a content of protein of from 0.01 to 10% by weight is preferred. Particularly preferred is an extract with a protein content of 0.01 to 5 wt.%. Furthermore, at least 30% by weight of glycerol are contained in the extract. Finally, water is contained in the extract according to the invention.
  • the above-described protein extract from the seeds of the Moringa growths is contained in an amount of at least 0.01 to 20% by weight.
  • amounts of the extract of 0.01 to 10 wt.%, Very particularly preferably amounts of 0.01 to 5 wt.% Based on the total cosmetic composition used.
  • Further preferred vegetable protein hydrolysates according to the invention are, for example, soya, almond, pea, potato and wheat protein hydrolysates.
  • Such products are, for example, under the trademarks Gluadin ® (Cognis), diamine ® (Diamalt) ® (Inolex), Hydrosoy ® (Croda), hydro Lupine ® (Croda), hydro Sesame ® (Croda), Hydro tritium ® (Croda) and Crotein ® (Croda) available.
  • protein hydrolysates according to the invention are of maritime origin. These include, for example, collagen hydrolyzates of fish or algae as well as protein hydrolysates of mussels or pearl hydrolyzates.
  • Beads of mussels consist essentially of inorganic and organic calcium salts, trace elements and proteins. Pearls can be easily obtained from cultivated mussels. The cultivation of the mussels can be done in fresh water as well as in sea water. This can affect the ingredients of the beads. According to the invention, preference is given to a pearl extract which originates from shells cultivated in marine or salt water. The pearls consist to a large extent of aragonite (calcium carbonate), conchiolin and an albuminoid. The latter components are proteins. Also included in beads are magnesium and sodium salts, inorganic silicon compounds, and phosphates. To prepare the pearl extract, the beads are pulverized. Thereafter, the pulverized beads are extracted by the usual methods.
  • water, alcohols and mixtures thereof can be used. Underwater are understood to mean both demineralized water and seawater.
  • the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as glycerol, diglycerol, triglycerol, polyglycerol, ethylene glycol, propylene glycol and butylene glycol, both as sole extractant and in admixture with demineralized water or sea water, preferably.
  • Pearl extracts based on water / glycerine mixtures have proven to be particularly suitable.
  • the pearl proteins can be largely in the native state or already partially or largely present as protein hydrolysates. Preference is given to a pearl extract in which conchiolin and albuminoid are already partially hydrolyzed.
  • the essential amino acids of these proteins are glutamic acid, serine, alanine, glycine aspartic acid and phenylalanine.
  • the bead extract is additionally enriched with at least one or more of these amino acids these amino acids.
  • the pearl extract is enriched with glutamic acid, serine and leucine.
  • a preferred extract contains organic and / or inorganic calcium salts as well as magnesium and sodium salts, inorganic silicon compounds and / or phosphates.
  • a most preferred pearl extract contains at least 75%, preferably 85%, more preferably 90% and most preferably 95% of all ingredients of the naturally occurring pearls.
  • pearl extracts according to the invention are the commercial products Pearl Protein Extract BG ® or Crodarom ® Pearl.
  • one of the above-described pearl extracts is contained in an amount of at least 0.01 to 20% by weight.
  • amounts of the extract of 0.01 to 10 wt.%, Very particularly preferably amounts of 0.01 to 5 wt.% Based on the total cosmetic composition used.
  • Another very special protein hydrolyzate is extracted from the silk.
  • Silk is a cosmetically very interesting fiber protein silk. By silk one understands the fibers of the cocoon of the mulberry silkworm (Bombyx mori L.).
  • the raw silk fiber consists of a double thread fibroin. As a cement substance, sericin holds this double thread together.
  • Silk consists of 70-80% by weight of fibroin, 19-28% by weight of sericin, 0.5-1% by weight of fat and 0.5-1% by weight of dyes and mineral constituents.
  • the essential components of sericin are with about 46 wt.% Hydroxyamino acids.
  • the sericin consists of a group of 5 to 6 proteins.
  • the essential amino acids of sericin are serine (Ser, 37% by weight), aspartate (Asp, 26% by weight), glycine (Gly, 17% by weight), alanine (Ala), leucine (Leu) and tyrosine (Tyr) ,
  • the water-insoluble fibroin belongs to the skieroproteins with a long-chain molecular structure.
  • the main components of the fibroin are glycine (44% by weight), alanine (26% by weight), and tyrosine (13% by weight).
  • Another important structural feature of the fibroin is the hexapeptide sequence Ser-Gly-Ala-Gly-Ala-Gly.
  • Preference according to the invention as active ingredients may be used: native sericin, hydrolyzed and / or further derivatized sericin, such as commercial products with the INCI names Sericin, Hydrolyzed Sericin, or Hydrolyzed SiIk, a mixture of the amino acids serine, aspartate and glycine and / or their Methyl, propyl, iso-propyl, butyl, iso-butyl esters, their salts such as hydrochlorides, sulfates, acetates, citrates, tartrates, wherein in this mixture, the serine and / or its derivatives to 20 to 60 wt.%, The aspartate and / or its derivatives to 10 to 40 wt.% And the glycine and / or its derivatives to 5 to 30 wt.% Are included, with the proviso that the amounts of these amino acids and / or derivatives thereof preferably to 100 wt.% supplement, as well as their mixtures.
  • the following can also be used as active ingredients: native fibroin converted into a soluble form, hydrolyzed and / or further derivatized fibroin, especially partially hydrolyzed fibroin, which contains as its main constituent the amino acid sequence Ser-Gly-Ala-Gly-Ala-Gly, the amino acid sequence Ser-Gly-Ala-Gly-Ala-Gly, a mixture of the amino acids glycine, Alanine and tyrosine and / or their methyl, propyl, iso-propyl, butyl, iso-butyl esters, their salts such as hydrochlorides, sulfates, acetates, citrates, tartrates, wherein in this mixture, the glycine and / or its derivatives in amounts of 20 60% by weight, containing alanine and its derivatives in amounts of 10-40% by weight, and the tyrosine and its derivatives in amounts of 0-25% by weight, with the proviso that
  • both silk protein hydrolysates and / or their derivatives are used simultaneously in the compositions according to the invention of the inventive composition, it may be preferred according to the invention that at least one of the two silk components, fibroin or sericin, is used in the native or, if appropriate, solubilized form. According to the invention, it is also possible to use a mixture of several silk protein hydrolysates and / or derivatives thereof.
  • the two silk protein hydrolysates are in the ratio of 10:90 to 70:30, in particular 15:85 to 50:50 and very particularly 20:80 be used to 40:60 based on their respective contents of active ingredient in the preparations of the invention.
  • the derivatives of sericin and fibroin hydrolysates include both anionic and cationized protein hydrolysates.
  • the protein hydrolysates of sericin and fibroin according to the invention and the derivatives prepared therefrom can be prepared from the corresponding proteins by chemical, in particular alkaline or acid hydrolysis, by enzymatic hydrolysis and / or a combination of the two Hydrolysis types are obtained.
  • the hydrolysis of proteins usually results in a protein hydrolyzate having a molecular weight distribution of about 100 daltons up to several thousand daltons.
  • cationic protein hydrolysates of sericin and fibroin and / or derivatives thereof whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 10,000 daltons.
  • cationic protein hydrolysates of sericin and fibroin also mean quaternized amino acids and mixtures thereof.
  • the quaternization of the protein hydrolyzates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides.
  • the cationic protein hydrolysates may also be further derivatized.
  • Typical examples of the cationic protein hydrolysates and derivatives of the present invention include the products commercially available under the INCI names: Cocodimonium Hydroxypropyl Hydrolyzed SiC, Cocodimonium Hydroxypropyl SiCl Amino Acids, Hydroxyproypltrimonium Hydrolyzed SiCl, Lauryldimony Hydroxypropyl Hydrolyzed SiIk, Steardimonium Hydroxypropyl Hydrolyzed Silica, Quaternium -79 Hydrolyzed SiIk.
  • anionic protein hydrolysates and derivatives according to the invention include the products mentioned under the INCI names and commercially available: Potassium Cocoyl Hydrolyzed Silicon, Sodium Lauroyl Hydrolyzed Silicon or Sodium Stearoyl Hydrolyzed Silicon. Finally, as typical examples of the derivatives of sericin and fibroin which can be used according to the invention, mention may be made of the products commercially available under the INCI names: Ethyl Ester of Hydrolyzed SiIk and Hydrolyzed SiIk PG-Propyl Methylsilanediol.
  • Palmitoyl Oligopeptide Palmitoyl Pentapeptide-3, Palmitoyl Pentapeptide-2, Acetyl Hexapeptide-1, Acetyl Hexapeptide-3, Copper Tripeptide-1, Hexapeptide-1 , Hexapeptide-2, MEA-Hydrolyzed SiIk.
  • compositions used according to the invention contain the silk protein hydroxysates and / or derivatives thereof in amounts of from 0.001 to 10% by weight, based on the total composition. Quantities of 0.005 to 5, in particular 0.01 to 3 wt .-%, are very particularly preferred.
  • protein hydrolysates is preferred as such, amino acid mixtures otherwise obtained may be used in their place, if appropriate.
  • derivatives of protein hydrolysates for example in the form of their fatty acid condensation products. Such products are sold, for example, under the names Lamepon® ® (Cognis), Lexein ® (Inolex), Crolastin ® (Croda) or crotein ® (Croda).
  • the protein hydrolysates (P) are present in the compositions in concentrations of 0.001% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of 0.05% by weight. up to 5% by weight.
  • compositions according to the invention can be further increased by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J).
  • Another object of the invention is therefore the use of derivatives of 2-pyrrolidinone-5-carboxylic acid.
  • Preference is given to the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion carries, in addition to hydrogen, one to three C 1 to C 4 -alkyl groups.
  • the sodium salt is most preferred.
  • the amounts used in the inventive compositions are 0.05 to 10 wt.%, Based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt.%.
  • compositions according to the invention with the active ingredient complex according to the invention are vitamins, provitamins or vitamin precursors.
  • Vitamins, pro-vitamins and vitamin precursors are particularly preferred, which are assigned to the groups A, B, C, E, F and H.
  • the skin which naturally also includes the scalp, leaves behind the treatment with these very particularly preferred components a much better-looking, more vital, stronger impression with significantly improved gloss and a very good grip both in the wet and in the dry state.
  • this drug affects the regeneration and restructuring of the affected skin and damaged hair, leads to a regulation of the fat balance, so that the thus treated skin and hair greases more slowly and not prone to over-greasing.
  • this ingredient has an anti-inflammatory and skin-calming effect.
  • the split hair is regenerated and repaired by these agents again. These ingredients are able to penetrate the hair and strengthen and repair the hair from the inside out. This "repair effect" can be demonstrated objectively by means of DSC measurements, for example, these effects can also be verified subjectively in the consumer test.
  • vitamin A includes retinol (vitamin A 1 ) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A component according to the invention for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration.
  • the agents according to the invention preferably contain the vitamin A component in amounts of 0.05-1% by weight, based on the total preparation.
  • the vitamin B group or the vitamin B complex includes vitamin B 1 (thiamine)
  • Vitamin B 2 (riboflavin)
  • Vitamin B 3 the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
  • Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.
  • panthenol pantothenic acid, panthenol and pantolactone.
  • Panthenol and / or pantolactone are preferably used in the context of this group.
  • usable derivatives of panthenol are in particular the esters and ethers of panthenol and cationically derivatized panthenols. Individual representatives are, for example, the panthenol triacetate, the panthenol monoethyl ether and its monoacetate and also the cationic panthenol derivatives disclosed in WO 92/13829.
  • the said compounds of the vitamin B 5 type are preferably contained in the agents according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred.
  • Vitamin B 6 pyridoxine and pyridoxamine and pyridoxal.
  • Vitamin C (ascorbic acid). Vitamin C is used in the agents according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.
  • Vitamin E tocopherols, especially ⁇ -tocopherol.
  • Tocopherol and its derivatives which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the agents according to the invention in amounts of 0.05-1% by weight, based on the total agent.
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile become established.
  • Biotin is preferably present in the agents according to the invention in amounts of from 0.0001 to 1.0% by weight, in particular in amounts of from 0.001 to 0.01% by weight.
  • compositions according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, E and H. panthenol, Pantolactone, pyridoxine and its derivatives as well as nicotinic acid amide and biotin are particularly preferred.
  • compositions according to the invention may additionally contain antimicrobial compounds.
  • Suitable antimicrobial compounds are, for. B. cationic surfactants such.
  • Good are also the antimicrobial biguanide compounds such.
  • the polyhexamethylene biguanide (Vantocil® IB, ICI) or the 1, 1 ' hexamethylene bis (4-chlorophenyl) biguanide (“chlorhexidine”) in the form of a water-soluble, compatible salt, e.g. In the form of the acetate or gluconate.
  • the antimicrobial 5-amino-hexahydropyrimidines z.
  • suitable antimicrobial agents are the non-cationic, phenolic, antimicrobial substances, in particular the halogenated phenols and diphenyl ethers. Particularly suitable antimicrobial compounds of this type are z. B. the
  • antimicrobial substances are the p-hydroxybenzoic acid esters and sesquiterpene alcohols such.
  • p-hydroxybenzoic acid esters such as the bisabolol, farnesol, Santalol or Nerolidol.
  • plant extracts (L) in the compositions according to the invention gives rise to further synergistic advantages. Therefore, the use of these substances is particularly advantageous.
  • Such combinations cause inter alia a pleasant fragrance of both the cosmetic composition, as well as the skin treated therewith and the treated hair.
  • these plant extracts according to the invention also favorably influence the moisture balance of the skin and the hair.
  • they have an anti-inflammatory and skin-calming effect when, for example, chamomile or valerian are used. Stinging nettles, hops, birch and burdock roots, for example, show particularly good hair-related effects.
  • extracts are produced by extraction of the whole plant. However, in individual cases it may also be preferred to prepare the extracts exclusively from flowers and / or leaves or the roots of the plant.
  • compositions according to the invention are the extracts of green tea, almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi and melon.
  • Ayurvedic plant extracts are used as plant extracts.
  • An ayurvedic plant extract is to be understood as any plant extract which has been prepared according to the principles of Ayurvedic teachings. The fundamentals of Ayurvedic teaching can be found in the so-called "Veda.” In Ayurvedic treatment with ayurvedic extracts and oils, three different treatments are usually performed by Ayurvedic therapists.
  • Ayurvedic plants include Aegle Marmelos (Bilwa), Cyperus Rotundus (Nagar Motha), Emblica officinalis (Amalki), Morida Citrifolia (Ashyuka), Tinospora Cordifolia (Guduchi), Santalum album, (Chandana), Crocus sativus (Kumkuma), Cinnamonum Zeylanicum and Nelumbo Nucifera (Kamala).
  • cosmetic compositions containing Aegle Marmelos (Bilwa), Cyperus Rotundus (Nagar Motha), Emblica Officinalis (Amalki), Tinospora Cordifolia (Guduchi), Crocus Sativus (Kumkuma), Cinnamonum Zeylanicum and Nelumbo Nucifera (Kamala).
  • Particularly preferred are cosmetic compositions containing Aegle Marmelos (Bilwa), Tinospora Cordifolia (Guduchi), Crocus Sativus (Kumkuma), Cinnamonum Zeylanicum and Nelumbo Nucifera (Kamala).
  • the teaching according to the invention also encompasses that mixtures of at least two of the ayurvedic plant extracts are used in the compositions according to the invention. In this case, it may be preferred if one of the ayurvedic plant extracts is bilwa.
  • Santalum album is one of the sandalwood plants.
  • Sandalwood is understood to mean woods of the family Fabaceae as well as woods of the family Santalaceae.
  • the Santalaceae family includes, for example, Santalum album, the sandalwood tree. This supplies the white or yellow sandalwood. From the yellow sandalwood essential oils, the sandalwood, are obtained, which are also used in Western homeopathy in the case of urinary tract infections or kidney disease. In cosmetics, these essential oils are used exclusively as perfume oils or as components of perfume oil compositions. In particular, the steam extracted products are used as perfume oil ingredients.
  • Aegle Marmelos or Bilwa is a member of the Rutaceae family, which are related to citrus fruits.
  • Bilwa is used especially in case of stomach ailments and diarrhea.
  • bilwa can help to improve the foaming behavior, such as foaming, foam volume, creaminess of the foam or the fine-poredness of the foam.
  • the necessary amount of surfactants and / or emulsifiers can be reduced. This in turn leads to a better compatibility of the respective cosmetic compositions.
  • these effects of the Bilwa are achieved.
  • Cyperus rotundus (Nagar motha) is a grassy plant. In Ayurvedic medicine as well as in Greek medicine Cyperus rotundus has been used as an anti-inflammatory.
  • Emblica officinalis is one of the oldest Indian fruits.
  • the fruits are exceptionally nutritious and contain large amounts of vitamin C, among other things. Since this fruit contains five of the six tastes of human taste perception, this fruit is considered the best fruit in Ayurvedic teachings and most useful for maintaining health and healing Considered diseases. Based on scientific research, it is known that this fruit contains unique tannins and flavonoids.
  • Citrifolia (Ashyuka) has been used to treat almost all diseases. In particular, however, high blood pressure, heart problems and diabetes were treated with it.
  • Tinospora Cordifolia (Guduchi) is one of the succulents. In Ayurvedic medicine, the plant is used as an anti-inflammatory, against arthritis and allergies.
  • Crocus sativus (Kumkuma) is widely used in India. It is used especially in rice dishes. In the teaching of Ayurveda it also serves as Aphrodisiac. Furthermore, it should have fever-lowering effects. In food it is used as a spice and for coloring foods.
  • Nelumbo nucifera is a lotus plant. Both in the Indian teachings of Ayurveda and in Chinese medicine, Lotus is described as a benefactor for the entire physique. Lotus is also the symbol of citizenship, beauty, wealth and fertility.
  • Cinnamomum Zeylanicum is used as a warming plant. It stimulates blood circulation, especially of the outer limbs such as fingers and feet. It is therefore also used for colds. It increases the bioavailability of other plant extracts. Furthermore, it is used as a spice for food and drinks.
  • it may be particularly preferable to use Cinnamomum Zeylanikum as Ayurvedic extract, if at the same time further plant extracts are to be used in the compositions according to the invention.
  • compositions according to the invention it is furthermore advantageously possible to use an extract of a sweetgrass.
  • Sweet grasses are botanically associated with the family Poaceae.
  • the Poaceae comprise about 9,000 known species in about 650 genera. Its distribution is worldwide.
  • the sweet grasses family have been very important for humans since ancient times.
  • the grasses include the cereals, but also sugar cane or lemongrass.
  • Chemically, especially the seeds of the sweet grasses contain high levels of proteins Prolamins and Glutamine.
  • Examples of particularly important representatives are wheat, barley, rye, oats, spelled, corn, the various types of millet (European millet, finger millet, millet as examples), sugar cane, ryegrass, meadow foxtail, oat oat, ostrich grass, meadow fescue, whistle grass, bamboo, cotton grass , also called cogon grass.
  • the grasses are used very widely by humans for nutrition, as medicinal plants or as building material.
  • the starch obtained from corn, rice or wheat is used.
  • essential oils such as citronella oil from Cymbopogon are already used in cosmetics.
  • the protein fractions obtained from the fruits of wheat are used to produce protein hydrolysates and their derivatives.
  • extracts of the roots of the respective grasses are used predominantly. Of course, however, extracts of all other plant parts can be used.
  • the Poaceae family is described in various textbooks. The details of each species vary between 9000 and 12000 species. However, the division into 13 subfamilies is uniform. The subfamilies as well as selected examples are:
  • Chloridoideae for example buffalo grass, silt grasses, dog tooth grasses or love grasses,
  • panicoideae for example cymbopogon (lemongrass), sugar cane, zea (corn), paniceae (millet), lamprey grasses, andropogonodeae (also known as imperium cylindrica, grass or cogon grass), 10) Bambusoideae, for example bamboo,
  • Ehrhartoideae for example Oryzeae (rice) or Zizania (wild rice),
  • Pooideae for example aveneae (oat grass, oat oat, oats, honey grasses, perennial oats), Poeae (grasses, bluegrasses), Triticeae (couch grass, barley, wheat, rye) and
  • all types are suitable according to the invention for obtaining an extract from the roots.
  • all root extracts of the Poaceae can also be used.
  • the use of root extracts which are particularly rich in alkali metals and alkaline earth metals, in elements of the I and II subgroups of the Periodic Table and in organic and / or inorganic sulfur are preferred. This applies in particular to the extracts of the subfamilies 8) to 12).
  • Preferred extracts are used from one of groups 9) to 12).
  • Particularly preferred is an extract from one of groups 9) and 10).
  • the extract of bamboo and flame grass is very particularly preferred.
  • Most preferred is the extract from the roots of the flame grass, Imperata Cylindrica.
  • Such a raw material for example, under the trade name Moist 24 ® by the company. Sederma commercially available.
  • an extract of the invention may be included as a component of drug capsules from which it is released during use.
  • active ingredient capsules may also have further independent effects in the agents according to the invention. Such effects may be, for example, an exfoliating effect caused by the capsule as such. In this case, however, the capsule shell is generally destroyed and released the active ingredient according to the invention extra kt and can in turn unfold its effect.
  • Such raw materials are available, for example from the company Cognis under the trade name Primasponge ® commercially.
  • An inventive Representative of these raw materials is for example Primaspong SS Ivory, which contains a bamboo extract according to the invention.
  • Another particularly preferred plant extract is an extract obtainable from plants of the genus Echinacea.
  • This is to be understood as meaning an extract which, according to the invention, comprises the plant itself, its plant parts, extracts and press juices of the sun-hat family (Echinacea, synonym: Brauneria Necker), in particular Echinacea angustifolia DC, Echinacea paradoxa (Norton), Echinacea simulata, E. atrorubens, E. tennesiensis, Echinacea strigosa (Mc Gregor), Echinacea laevigata, Echinacea purpurea (L.) Moench and Echinacea pallida (Nutt), as well as to understand from these extracts to be recovered active substances.
  • Particular preference is given to using pressed juices and extracts of sun-hatch plants, in particular of Echinacea purpurea (L) Moench.
  • the pressed juices or extracts of herb (the above-ground parts of plants) and / or root of Sonnenhutgewumblese be obtained.
  • the pressed juices are preferably obtained by mechanical pressing. Particularly preferred is a pressing according to the patented by the company. Flachsmann method according to EP 0 730 830 B1, the disclosure of which is hereby incorporated by reference in its entirety.
  • the extracts may be prepared with water, as well as polar or nonpolar organic solvents, as well as mixtures thereof in a manner known to those skilled in the art. Extracts that can be obtained by extraction with ethanol or water / ethanol mixtures and press juice are preferred.
  • extracts both in the original extractant and extracts / compressed juice in water or other organic solvents and / or mixtures thereof, in particular ethanol and ethanol / water mixtures.
  • extracted or pressed material is used as a solid to which the solvent (in particular as gently as possible) was removed.
  • those extracts / compressed juices to which the solvent has been partly removed, so that a thickened extract / compressed juice is used. All particularly preferred are pressed juices from the fresh Echinacea purpurea herb (Echinacea purpurea Moench herba).
  • the extracts and / or compressed juices are used in solid form.
  • the active ingredient obtainable from plants of the genus Echinacea selected from pressed juices and extracts obtained from Echinacea purpurea.
  • alcohols and mixtures thereof can be used as extraction agent for the preparation of said plant extracts water.
  • the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as sole extractant and in admixture with water, are preferred.
  • Plant extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.
  • the plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture.
  • compositions according to the invention mixtures of several, especially two, different plant extracts.
  • rock crystal extract In addition to the plant extracts, a rock crystal extract has also recently been used in cosmetic compositions.
  • Rock crystal is a modification of silica.
  • Silica itself is also included in many other clays and earths as a companion material.
  • quartz is found in bentonite. Quartz in the form of various silicates is also used, for example, in homeopathic remedies, for example sodium aluminum silicate for the reduction of heartburn or also in the medicine of Ayurveda.
  • Sand which can be contaminated with quartz, finds use in cleansing cosmetic products as exfoliating body.
  • quartz has a mystical meaning. So the rock crystal is considered something special.
  • Contaminants are not understood to mean the traces of other elements embedded in them, which contribute to the color of the rose quartz, for example.
  • the term "quartz” understood silicates, phyllosilicates, talcs, spades, etc.
  • Finely ground quartz and an extract of finely ground quartz is used in cosmetic compositions to give the skin and hair a velvety, soft, pleasant feeling. Furthermore, the gloss of skin and hair is remarkably increased significantly. However, there is no undesirable stress on the skin and hair. Also on the hair subsequent treatments such as cold wave or dyeing processes are not only not adversely affected but there is no impairment.
  • the finely ground quartz, the quartz powder is obtained by conventional methods for comminution and grinding of rocks. Quartz powder is used especially in particle sizes from 0.5 ⁇ m up to 500 ⁇ m. Particular preference is given to particle sizes of from 0.5 to 250 ⁇ m, very particularly preferably from 10 ⁇ m to 200 ⁇ m.
  • the finely ground Extracting quartz with the help of protic solvents and the resulting quartz extract is used in the cosmetic compositions.
  • extraction agent for the preparation of said quartz extracts water, alcohols and mixtures thereof can be used.
  • Underwater are to be understood here as demineralized water, as well as seawater and mineral water.
  • alcohols are lower alcohols such as ethanol, isopropanol, butanol, iso-butanol, tert.
  • the invention also includes the teaching that, of course, a plurality of alcohols and / or polyhydric alcohols can be used as extractant in admixture with water.
  • mineral water is to be understood water, which natural originates from mineralized sources.
  • the mineral waters include Evian, SpA, Leau de Vichy, etc.
  • any known methods such as hot extraction or other methods may be used.
  • a quartz extract thus obtained usually contains at least 1 to 100,000 ppm of silicon.
  • Preferred is an extract with a minimum amount of silicon of 10 ppm.
  • an extract with a content of silicon of at least 50 ppm is particularly preferred. Most notably preferred is an extract with a content of at least 100 ppm. Most preferred is a content of at least 200 ppm silicon.
  • the amount of silicon in the extract is determined by flame spectrometry in distilled water.
  • the quartz extract may optionally be adjusted with water glass to a constant minimum content of silicon. If water glass is used to set a constant silicon content, it may still be necessary to adjust the pH of the quartz extract.
  • the quartz extract usually has a pH of from 4 to 11, preferably from 6 to 11, more preferably from 7 to 10, and most preferably from 7.5 to 9.5.
  • the pH value will be adjusted with mineral acids such as aqueous solutions of hydrogen halides, sulfuric acid and its salts, sulphurous acid and its salts, phosphorous acid and its salts, phosphoric acid and salts thereof or with organic acids Acids and their salts such as iminodisuccinic acid, etidronic acid, tartaric acid or citric acid made.
  • acids which also have complex-forming properties, may be preferred. These include, for example, phosphoric acid, iminodisuccinic acid, etidronic acid, tartaric acid or citric acid and their salts. Very particular preference is given to using phosphoric acid in the case of a necessary pH adjustment.
  • An example of a commercially available quartz extract is available under the name Crodarom ® rock crystal by Croda free in the trade.
  • the agents according to the invention may contain purine and / or derivative (s) of purine.
  • Purine (7 / - / - imidazo [4,5-c /] pyrimidine) does not occur freely in nature, but forms the main body of the purines.
  • Purines are a group of important compounds naturally involved in human, animal, plant and microbial metabolic processes which are different from the parent by substitution with OH, NH 2 , SH at the 2-, 6-, and 8-positions and / or with CH 3 in 1-, 3-, 7-position derived.
  • Purine can be prepared, for example, from aminoacetonitrile and formamide.
  • Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.
  • compositions of the invention contain purine and / or purine derivatives in narrower ranges.
  • inventively preferred cosmetic agents characterized in that they - based on their weight - 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).
  • compositions are particularly preferred according to the invention.
  • Cosmetic agents preferred according to the invention are characterized in that they contain purine and / or purine derivative (s) of the formula (I)
  • radicals R 1 , R 2 and R 3 are selected independently of one another from -H, - OH, -
  • NH 2 , -SH and the radicals R 4 , R 5 and R 6 are independently selected from -H, -CH 3 and -CH 2 -CH 3 , where the following compounds are preferred:
  • the cosmetic agent may vary the nature and amount of purine derivative.
  • purine derivative in hair cosmetic formulations has become
  • caffeine proven useful, for example, in shampoos, conditioners, hair lotions and / or lotions preferably in amounts of 0.005 to 0.25 wt .-%, more preferably from 0.01 to 0.1 wt .-% and in particular of 0.01 to 0.05 wt .-% (in each case based on the shampoo) can be used.
  • compositions according to the invention contain penetration aids and / or swelling agents (M).
  • M penetration aids and / or swelling agents
  • These excipients provide better penetration of active ingredients into the keratin fiber or help swell the keratin fiber.
  • gencarbonates diols and triols, and in particular 1, 2-diols and 1, 3-diols such as 1, 2-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-dodecanediol, 1, 3-propanediol , 1, 6-hexanediol, 1, 5-pentanediol, 1, 4-butanediol.
  • 1, 2-diols and 1, 3-diols such as 1, 2-propanediol, 1, 2-pentanediol, 1, 2-hexanediol, 1, 2-dodecanediol, 1, 3-propanediol , 1, 6-hexanediol, 1, 5-pentanediol, 1, 4-butanediol.
  • a particularly preferred group of swelling agents may be hydantoins.
  • Hydantoins show several desirable beneficial effects in cosmetic compositions. One of these effects is their ability to favorably influence the swelling of the skin and hair. Therefore, compositions of the invention preferably contain 0.01 to 5 wt .-% hydantoin or at least one Hydatoinderivates.
  • Hydantoin derivatives are particularly preferably used according to the invention, with 5-ureidohydantoin being particularly preferred.
  • hydantoin or hydantoin derivative (s) is / are used, amounts of from 0.02 to 2.5 wt .-% are very particularly preferred, from 0.05 to 1, 5 wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% - each based on the total agent - most preferably.
  • cosmetic agents according to the invention which contain 0.02 to 2.5% by weight, preferably 0.05 to 1.5% by weight, more preferably 0.075 to 1% by weight and in particular 0.1 to 0, 25% by weight of hydantoin and / or hydantoin derivative (s), preferably 5-ureidohydantoin (allantoin) contain.
  • biochinones Another group of very particular ingredients of the compositions of the invention are biochinones.
  • suitable biochinones are understood as meaning one or more ubiquinone (s) and / or plastoquinone (s).
  • the preferred ubiquinones according to the invention have the following formula:
  • Plastoquinones have the general structural formula
  • the or the biochinone (s) is (are) in the inventive compositions - by weight - in an amount of 0.0000005 to 2%, preferably in an amount of 0.000001 to 1% and in particular in an amount of 0 , 00001 to 0.5%.
  • betaines are also particularly preferred group of ingredients in the cosmetic compositions of the invention.
  • Betaines are not to be understood Betaine with surface-active properties, as described in the chapter on surfactants or emulsifiers.
  • a betaine means compounds which simultaneously contain both a grouping -NR 3 (+) and a grouping -CR 2 COO (") , analogously constructed sulfobetaines and compounds which have a grouping -NR 3 + and a grouping -CH 2 OH.
  • This definition is based on the definition in Rompp 's Lexikon Chemie - CD-ROM Version 2.0, Stuttgart / New York, Georg Thieme Verlag 1999.
  • the betaines according to the invention are to be understood as meaning those which Correspond to formula (AI).
  • R 1 , R 2 , and R 3 here independently of one another represent:
  • R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are here independently of one another:
  • a C 2 -C 8 saturated or unsaturated, branched or linear or cyclic hydrocarbon radical where R 10 is hydrogen, -CH 3 or a C 2 -C 30 saturated or unsaturated, branched or linear or cyclic hydrocarbon radical and R 11 is -CH 3 or a C2 - C30 saturated or unsaturated, branched or linear or cyclic hydrocarbon radical, x, y and z are each independently an integer from 0 to 12, with the proviso that at least one of the parameters x, y or z is different from 0 and Y " represents COO " , SO 3 " or a hydroxy group in combination with a physiologically acceptable anion.
  • betaines are also to be understood as meaning those substances in which the mentioned characteristic groups are present only in the case of the dissolved substance and within certain pH ranges of the solution.
  • mixed salts are solid solutions of various substances.
  • mixed crystals for example, refer to HR Christians, Fundamentals of General and Inorganic Chemie, Sauerlander and SaIIe, 5th edition, 1977, on page 245 and expressly incorporated by reference.
  • the inorganic mixed salts such as hydrochlorides, hydrobromides, hydroiodides, sulfates, sulfites, hydrogen sulfates, hydrogen sulfites, carbonates and bicarbonates, mono-, di-, triphosphates or mixtures of phosphates and mixtures of these mixed salts of the betaines according to the invention can be used .
  • the mixed salts of the betaines according to the invention can be used with organic carboxylic acids.
  • Suitable examples of such acids are, for example, formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, oxalic acid, malonic acid, succinic acid, glutaric acid, glyceric acid, glyoxylic acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, propiolic acid, crotonic acid, isocrotonic acid , Elaidic, maleic, fumaric, muconic, citraconic, mesaconic, camphoric, benzoic, 4-hydroxybenzoic, o, m, p-phthalic, naphthoic, toluoic, hydratropic, atropic, salicylic, cinnamic, isonicotinic, nicotinic, bicarbamic, 4.4 '-Dicyano-6,6'-binico
  • organic polyfunctional carboxylic acids which, in addition to at least one carboxy group, additionally have at least one hydroxyl group and / or at least one amino group.
  • organic carboxylic acids are glycolic acid, lactic acid, malic acid, tartaric acid or citric acid, etc., which are attributable to the edible acids.
  • amino acids such as histidine, arginine, lysine, citrulline, etc. are among the polyfunctional organic acids which can be used as mixed salts with the active compounds (I) according to the invention.
  • the mixing ratio of the mixed salts according to the invention can be between 1: 50 and 50: 1, preferably between 10: 1 and 1:10, and very particularly preferably based on the respective molar masses of the individual components (betaine of the formula (I) / mixed salt-forming substance) between 3: 1 and 1: 3.
  • betaines of the formula (AI) are: carnitine, carnitine tartrate, carnitine magnesium citrate, acetyl carnitine, 3-O-lauroyl L-carnitine hydrochloride, 3-O-octanoyl L-carnitine hydrochloride, 3 O-palmitoyl L-carnitine hydrochloride, taurine, tauryl lysylate, taurine tartrate, taurine ornithine, lysyl taurine and ornithyl taurine, betalain, 1, 1-dimethyl-proline, hercynin (N ⁇ , N ⁇ , N ⁇ -trimethyl-L-histidinium betaine), Ergothionein (thionein, 2-mercapto-N ⁇ , Na, Na-trimethyl-L-histidinium betaine), choline, choline chloride, choline bitartrate, choline dihydrogen citrate, and the compound N, N, N
  • compositions according to the invention may contain both a compound according to formula (A-I) and several, in particular two, compounds of formula (A-I).
  • the agents according to the invention contain the betaines in amounts of from 0.001 to 20% by weight, based on the total agent. A content of 0.05 to 10 wt .-% is preferred. All types of isomers, such as diastereomers, enantiomers, isocyanate trans isomers, optical isomers, conformational isomers and racemates can be used according to the invention.
  • compositions according to the invention may contain both a compound according to formula (A-I) and several, in particular two, compounds of formula (A-I).
  • compositions according to the invention may contain pharmacologically active substances to achieve certain effects, such as, for example, an anti-dandruff effect or effects against acne.
  • Examples of pharmacologically active substances are corticosteroids, ⁇ -blockers, estrogens, phytoestrogens, cyproterone acetate, vasodilating substances such as diazoxide, nifedipine and minoxidil, acetylsalicylic acid or salicylic acid.
  • compositions according to the invention are particularly well suited to deposit perfume oils or perfumes on the skin and hair in an increased amount. At the same time the perfume oils and fragrances remain much longer on the skin or the hair adhere. This leads to an increased acceptance of such compositions in the consumer.
  • compositions of the invention are perfumes.
  • perfumes are perfumes.
  • the excellent and completely surprising positive results of compositions containing the active compounds and perfumes according to the invention has already been described in detail above.
  • perfume means perfume oils, fragrances and fragrances.
  • perfume oils are called mixtures of natural and synthetic fragrances.
  • Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (aniseed, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (macis, angelica, celery, cardamom, costus, iris, calmus), wood (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme, chamomile ), Needles and twigs (spruce, fir, pine, pines), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • animal raw materials come into question, such as civet and Castoreum.
  • Typical synthetic fragrance compounds are ester type products, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are known e.g. Benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate, phenylethylacetate, linalylbenzoate, benzylformate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, cyclohexylsalicylate, floramate, melusate, jasmecyclate and benzylsalicylate.
  • Fragrance compounds of the ester type are known e.g. Benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohe
  • the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes e.g. the linear alkanals of 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones e.g.
  • the ionones ° ⁇ -symethylionone and methylcedryl ketone, the alcohols anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol;
  • the hydrocarbons mainly include the terpenes and balms such as limonene and pinene.
  • fragrance oils are suitable as perfume oils, eg sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil.
  • bergamot oil dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, ⁇ -hexyl cinnamaldehyde, geraniol, benzylacetone, Cyclamenaldehyde, Linalool, Boisambrene Forte, Ambroxan, Indole, Hedione, Sandelice, Citrus oil, Tangerine oil, Orange blossom oil, Orange peel oil, Sandalwood oil, Neroliol allylamyl glycolate, Cyclovertal, Lavandin oil, Muscat sage oil, B-Damascone, Bourbon geranium oil, Cyclohexyl salicylate, Vertofix Coeur, Iso-E Super, fixolide NP, evernyl, iraldeine gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilllat
  • fragrances which may be present in the compositions according to the invention are found, for example, in US Pat. In S. Arctander, Perfume and Flavor Materials, Vol. I and II, Montclair, NJ, 1969, Dverlag or K. Bauer, D. Garbe and H. Surburg, Common Fragrance and Flavor Materials, 3 rd . Ed., Wiley-VCH, Weinheim 1997.
  • a fragrance In order to be perceptible, a fragrance must be volatile, with molecular weight also playing an important role in addition to the nature of the functional groups and the structure of the chemical compound. For example, most odorants have molecular weights up to about 200 daltons, while molecular weights of 300 daltons and above are more of an exception. Due to the different volatility of fragrances, the smell of a perfume or fragrance composed of several fragrances changes during evaporation, whereby the odor impressions in "top note", “middle note or body” As the smell perception is based to a large extent on the odor intensity, the top note of a perfume or fragrance consists not only of volatile compounds, while the base note for the most part from less volatile , ie adherent fragrances.
  • Adhesive-resistant fragrances which are advantageously usable in the context of the present invention are, for example, the essential oils such as angelica root oil, aniseed oil, Arnica blossom oil, basil oil, bay oil, bergamot oil, Champacablütenöl, Edeltannenöl, Edeltannenzapfenapfen, Elemiöl, eucalyptus oil, fennel oil, spruce oil, galbanum oil, geranium oil, gingergrass oil , Guaiac wood oil, gurdy balm oil, helichrysum oil, ho oil, ginger oil, iris oil, cajeput oil, calamus oil, chamomile oil, camphor oil, kanaga oil, cardamom oil, cassia oil, pine needle oil, copa ⁇ va balsam oil, coriander oil, spearmint oil, cumin oil, cumin oil, lavender oil, lemongrass oil, lime oil, tangerine oil, lemon balm oil .
  • the essential oils such as
  • fragrances can be used in the context of the present invention advantageously as adherent fragrances or fragrance mixtures, ie fragrances.
  • These compounds include the following compounds and mixtures thereof: ambrettolide, amylcinnamaldehyde, anethole, anisaldehyde, anisalcohol, anisole, methyl anthranilate, acetophenone, benzylacetone, benzaldehyde, ethyl benzoate, benzophenone, benzyl alcohol, benzyl acetate, benzyl benzoate, benzyl formate, benzyl valerate, borneol, Bornyl acetate, bromostyrene, n-decyl aldehyde, n-dodecyl aldehyde, eugenol, eugenol methyl ether, eucalyptol, farnesol,
  • more volatile fragrances which are advantageously used in the context of the present invention, include in particular the lower-boiling fragrances natural or synthetic origin, which may be used alone or in mixtures.
  • Examples of more readily volatile fragrances are alkyl isothiocyanates (alkyl mustard oils), butanedione, limonene, linalool, linayl acetate and propionate, menthol, menthone, methyl-n-heptenone, phellandrene, phenylacetaldehyde, terpinyl acetate, citral, citronellal.
  • boiling points of the individual fragrances are substantially below 300 ° C.
  • a preferred embodiment of the invention wherein preferably at least 50% of the fragrances contained have a boiling point below 300 ° C., advantageously at least 60%, more preferably at least 70%. , in an even more advantageous manner at least 80%, in an extremely advantageous manner at least 90%, in particular even 100%.
  • Boiling points below 300 ° C are therefore advantageous because the fragrances would have too low a volatility at higher boiling points.
  • a certain volatility of the fragrances is advantageous.
  • Unstable fragrances for the purposes of this invention can be identified by incorporating a perfume composition comprising at least 6 fragrances into activated / dehydrated zeolite X and storing the resulting sample for 24 hours at room temperature. Then the fragrances are extracted with acetone and analyzed by gas chromatography to determine the stability.
  • a fragrance is then considered to be unstable in the sense of this invention, if at least 50 wt .-%, preferably at least 65 wt .-%, advantageously at least 80 wt .-%, in particular at least 95 wt .-% of this perfume decomposed into degradation products and in the extraction could not be provided again.
  • the unstable perfume in particular the group of allyl alcohol esters, esters of secondary alcohols, esters of tertiary alcohols, allylic ketones, condensation products of amines and aldehydes, Acetals, ketals and mixtures of the foregoing.
  • perfume adsorbed in / on the particle ad / at least 4 advantageously at least 5, in a further advantageous manner at least 6, more preferably at least 7, even more preferably at least 8, preferably at least 9, in particular at least Contains 10 different fragrances, so is a preferred embodiment of the invention.
  • the logP value of the perfume components adsorbed in / on the particle ad / is substantially at least 2, preferably at least 3 or greater, so that at least 40%, advantageously at least 50%, more preferably at least 60%, more preferably at least 70%, preferably at least 80%, in particular 90% of the perfume components fulfill this log requirement, then a preferred embodiment of the invention is present.
  • the logP value is a measure of the hydrophobicity of the perfume components. It is the decadic logarithm of the partition coefficient between n-octanol and water.
  • the octanol / water partition coefficient of a perfume ingredient is the ratio between its equilibrium concentrations in water and octanol.
  • a perfume ingredient with higher partition coefficient P is more hydrophobic.
  • the stated conditions for the logP are advantageous because it ensures that the fragrances can be better retained in the pores of the support material and also better on objects which are treated with the particles (for example, indirectly by treatment with a detergent formulation, which comprises the particles according to the invention) precipitate.
  • the logP value of many perfume ingredients is given in the literature; For example, the Pomona 92 database, available from Daylight Chemical Information Systems, Inc. (Daylog CIS) of Irvine, California, contains many such values along with references to the original literature.
  • the logP values can also be calculated, for example, with the "CLOG P" program of the aforementioned company Daylight CIS.
  • Clog P the "CLOG P" program of the aforementioned company Daylight CIS.
  • Clog-P values should also be used for hydrophobicity estimation if there are no experimental logP values for certain perfume ingredients.
  • the perfume can also be combined with a perfume fixative. It is believed that perfume fixatives can slow the exhalation of higher volatile fractions of perfume.
  • the perfume which is adsorbed in / on the carrier material comprises a perfume fixative, preferably in the form of diethyl phthalates, musk (derivatives) and mixtures thereof, the fixative amount preferably being from 1 to 55% by weight. , Advantageously, 2 to 50 wt .-%, more preferably 10 to 45 wt .-%, in particular 20 to 40 wt .-% of the total amount of perfume.
  • the particles contain an agent which increases the viscosity of liquids, in particular perfume, preferably PEG (polyethylene glycol), advantageously having a molecular weight of from 400 to 2000, wherein the viscosity-increasing agent in a preferred manner in amounts of 0.1 to 20 wt .-%, advantageously from 0.15 to 10 wt .-%, more preferably from 0.2 to 5 wt .-% , in particular from 0.25 to 3 wt .-%, based on the particles.
  • PEG polyethylene glycol
  • the viscosity-increasing agents are preferably polyethylene glycols (PEG for short) which can be described by the general formula I:
  • n of about 5 to> 100,000 corresponding to molecular weights of 200 to 5,000,000 gmol-1, may vary.
  • the products with molecular weights below 25,000 g / mol are referred to as actual polyethylene glycols, while higher molecular weight products are often referred to in the literature as polyethylene oxides (PEOX for short).
  • the polyethylene glycols preferably used may have a linear or branched structure, with particular preference being given to linear polyethylene glycols and end-capped.
  • the particularly preferred polyethylene glycols include those having molecular weights between 400 and 2000. It can be used in particular also polyethylene glycols, which are present in a liquid state at room temperature and a pressure of 1 bar; Here is mainly of polyethylene glycol with a molecular weight of 200, 400 and 600 the speech.
  • the perfumes are generally added in an amount of 0.05 to 5 wt .-%, preferably from 0.1 to 2.5 wt .-%, particularly preferably from 0.2 to 1.5 wt .-%, based on the total composition, of the total composition.
  • the perfumes may be added to the compositions in liquid form, neat or diluted with a solvent for perfuming. Suitable solvents for this purpose are, for. For example, ethanol, isopropanol, diethylene glycol monoethyl ether, glycerol, propylene glycol, 1, 2-butylene glycol, dipropylene glycol, diethyl phthalate, triethyl citrate, isopropyl myristate, etc.
  • the perfumes for the compositions of the present invention may be adsorbed to a carrier which provides both a fine distribution of the fragrances in the product and a controlled release in use.
  • a carrier which provides both a fine distribution of the fragrances in the product and a controlled release in use.
  • Such carriers can be porous inorganic materials such as light sulfate, silica gels, zeolites, gypsum, clays, clay granules, aerated concrete, etc., or organic materials such as woods and cellulosic based materials.
  • perfume oils for the compositions according to the invention can also be microencapsulated, spray-dried, present as inclusion complexes or as extruded products and added in this form to the compositions to be perfumed.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des compositions cosmétiques destinées à purifier et soigner la peau et les cheveux, contenant: a) un extrait de champagne. L'utilisation de ce produit permet un maintien amélioré, de manière significative, et prolongé de l'hydratation de la peau et des cheveux, ainsi qu'un sentiment de confort amélioré significativement au niveau de la peau et des cheveux.
PCT/EP2008/054254 2007-06-28 2008-04-09 Composition cosmétique contenant un extrait de champagne WO2009000570A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007030099.0 2007-06-28
DE102007030099A DE102007030099A1 (de) 2007-06-28 2007-06-28 Kosmetische Zusammensetzung enthaltend einen Champagner-Extrakt

Publications (2)

Publication Number Publication Date
WO2009000570A2 true WO2009000570A2 (fr) 2008-12-31
WO2009000570A3 WO2009000570A3 (fr) 2009-11-26

Family

ID=40075989

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/054254 WO2009000570A2 (fr) 2007-06-28 2008-04-09 Composition cosmétique contenant un extrait de champagne

Country Status (2)

Country Link
DE (1) DE102007030099A1 (fr)
WO (1) WO2009000570A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090324505A1 (en) * 2008-06-30 2009-12-31 Jeffery Richard Seidling Surfactant gas pressurized liquid composition and method and package for delivering
US20130005681A1 (en) * 2011-06-30 2013-01-03 Depuy Mitek, Inc. Compositions and methods for stabilized polysaccharide formulations

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011089576A1 (de) * 2011-12-22 2013-06-27 Henkel Ag & Co. Kgaa Mildes Gesichtsreinigungsmittel mit Haut pflegenden Eigenschaften
DE102020125873A1 (de) * 2020-10-02 2022-04-07 Dr. Kurt Wolff Gmbh & Co. Kg Zusammensetzung zur Behandlung von Haaren und der Kopfhaut
DE102020214353A1 (de) 2020-11-16 2022-05-19 Beiersdorf Aktiengesellschaft Emulsion enthaltend Ceratonia Siliqua Gum und Aluminium Chlorohydrate
US12296041B2 (en) * 2021-04-29 2025-05-13 L'oreal Hair care compositions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237253A (en) 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
DE3172768D1 (en) 1980-09-05 1985-12-05 Ciba Geigy Ag Mixtures of polymeric high-molecular acrylic quaternary ammonium salts and detergents, their preparation and use in cosmetic formulations
JPS5813700A (ja) 1981-07-17 1983-01-26 花王株式会社 食器用洗浄剤組成物
DE3139438A1 (de) 1981-10-03 1983-04-21 Henkel KGaA, 4000 Düsseldorf Verwendung kolloidaler loesungen von seidenfibroin in haarkosmetischen mitteln und haarshampoo
EP0217274A3 (fr) 1985-09-30 1988-06-29 Kao Corporation Composition cosmétique pour les cheveux
FR2610197B1 (fr) * 1987-02-03 1992-04-03 Futur Quotidien Sa Composition aromatique pour la therapeutique des dependances alcooliques comme pour l'hygiene corporelle ainsi que son procede de preparation
CH672066A5 (fr) 1987-02-20 1989-10-31 Modima Sa
DE3708451A1 (de) 1987-03-16 1988-10-06 Henkel Kgaa Zwitterionische polymere und deren verwendung in haarbehandlungsmitteln
US4784847A (en) * 1987-04-28 1988-11-15 Zulliger Bopp Monika G Wine-containing skin-care products
DE3929173A1 (de) 1989-09-02 1991-03-07 Henkel Kgaa Verfahren zur haarfaerbung mit direktfarbstoffen
DE3929973A1 (de) 1989-09-08 1991-03-14 Henkel Kgaa Haarpflegemittel
US5136093A (en) 1991-02-06 1992-08-04 Smith Ronald J Quaternized panthenol compounds and their use
DE4413686C2 (de) 1994-04-20 1996-10-24 Henkel Kgaa Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung
US5906848A (en) 1995-03-06 1999-05-25 Emil Flachsmann Ag Process for the removal of undesired contaminations and/or residues contained in beverages or in vegetable preparation
JPH10158145A (ja) * 1996-11-26 1998-06-16 Mercian Corp 化粧料
DE19738866A1 (de) 1997-09-05 1999-03-11 Henkel Kgaa Schaumarme Tensidmischungen mit Hydroxymischethern
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
ATE270685T1 (de) 2000-07-27 2004-07-15 Ge Bayer Silicones Gmbh & Co Polyammonium-polysiloxan-verbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE10053051C2 (de) * 2000-10-13 2002-10-31 Coty Bv Kosmetische Zubereitung mit Pflanzenextrakten
US20070009473A1 (en) * 2005-07-08 2007-01-11 Walker Robert W Vintage dated wine soap
DE202006006675U1 (de) * 2006-04-26 2006-09-28 Wohnhas, Theda Kosmetisches Mittel zur Verbesserung der Haut
DE202006006877U1 (de) * 2006-04-29 2006-10-12 Wohnhas, Theda Kosmetisches Mittel mit Champagner und Shiitake zur Verschönerung der Haut

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090324505A1 (en) * 2008-06-30 2009-12-31 Jeffery Richard Seidling Surfactant gas pressurized liquid composition and method and package for delivering
US8691301B2 (en) * 2008-06-30 2014-04-08 Kimberly-Clark Worldwide, Inc. Surfactant gas pressurized liquid composition and method and package for delivering
US20130005681A1 (en) * 2011-06-30 2013-01-03 Depuy Mitek, Inc. Compositions and methods for stabilized polysaccharide formulations
US8623839B2 (en) * 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations

Also Published As

Publication number Publication date
DE102007030099A1 (de) 2009-01-02
WO2009000570A3 (fr) 2009-11-26

Similar Documents

Publication Publication Date Title
DE102006061863A1 (de) Haarkonditionierende Mittel mit ausgewählten kationischen Polymeren und wasserlöslichen Silikonen
EP1800715A1 (fr) Système cosmétique (kit) de traitement des cheveux et du cuir chevelu
DE102005062268A1 (de) Pulverförmige Stylingmittel und deren Spendersysteme
WO2007079793A1 (fr) Soins capillaires à base de polymères hyper-ramifiés
WO2008080701A1 (fr) Compositions cosmétiques contenant des acides gras choisis et du squalène
DE102008035172A1 (de) Strukturierte Zusammensetzung mit optimalen Lager-Stabilitäts-Eigenschaften
WO2009000570A2 (fr) Composition cosmétique contenant un extrait de champagne
WO2009074464A2 (fr) Conditionneurs capillaires contenant des composés cationiques et des silicones sélectionnées et/ou des huiles cosmétiques
EP2061422A2 (fr) Poudre minérale naturelle dans des produits cosmétiques
WO2008080708A1 (fr) Composition cosmétique contenant de l'huile d'argan et du beurre de karité
DE10358587A1 (de) Volumengebendes kosmetisches Mittel
WO2008074576A1 (fr) Composition conditionnante de polymères amphotères ou cationiques et de tensioactifs anioniques doux spécialement sélectionnés dans des moyens de traitement de fibres kératiniques
DE102006004714A1 (de) Pflegende Haarbehandlungsmittel mit Proteinhydrolysat(en)
DE102004040172A1 (de) Kompakthaarspray
DE102007029061A1 (de) Haut- und Haarbehandlungsmittel mit einem Extrakt eines Süßgrases
DE102007001008A1 (de) Kosmetische Wirkstoffzusammensetzung mit Ayurveda-Extrakten
DE10358780A1 (de) Versprühbares Gel
DE102006061555A1 (de) Synergistische Kombination von Seidenproteinen und ausgewählten Metallen
WO2008025679A1 (fr) Composition de principes actifs cosmétique contenant de l'extrait de bois de santal
WO2007000223A1 (fr) Produits cosmetiques contenant un compose de polyammonium-polysiloxane et d'autres principes actifs
DE102006018343A1 (de) Kunststoffhohlkörper
DE102009031432A1 (de) Kompaktes Haarspray
EP2209461A1 (fr) Produit de traitement capillaire avec extrait de litchi et taurine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08735980

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08735980

Country of ref document: EP

Kind code of ref document: A2